0001437749-18-020775.txt : 20181114 0001437749-18-020775.hdr.sgml : 20181114 20181114145804 ACCESSION NUMBER: 0001437749-18-020775 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181114 DATE AS OF CHANGE: 20181114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: McorpCX, Inc. CENTRAL INDEX KEY: 0001535079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 260030631 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54918 FILM NUMBER: 181182941 BUSINESS ADDRESS: STREET 1: 201 SPEAR STREET STREET 2: SUITE 1100 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: (415) 526-2655 MAIL ADDRESS: STREET 1: 201 SPEAR STREET STREET 2: SUITE 1100 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: Touchpoint Metrics, Inc. DATE OF NAME CHANGE: 20111116 10-Q 1 mccx20180930_10q.htm FORM 10-Q mccx20180930_10q.htm
 

 



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED

September 30, 2018

 

 

OR

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number:   000-54918

 

MCORPCX, INC.

(Exact name of registrant as specified in its charter)

 

California

(State or other jurisdiction of incorporation or organization)

 

26-0030631

(I.R.S. Employer Identification No.)

 

201 Spear Street, Suite 1100

San Francisco, CA   94105

(Address of principal executive offices, including zip code)

 

(415) 526-2655

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.   YES      NO

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   YES      NO

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer

Accelerated Filer

Non-accelerated Filer

(Do not check if a smaller reporting company)

Smaller Reporting Company

Emerging growth company

  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   YES      NO

  

Indicated the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: 20,426,158 as of November 9, 2018.  

 

 

 

 

MCORPCX, Inc.

Form 10-Q Quarterly Report

 

 

TABLE OF CONTENTS

 

 

 

Page

No.

 

 

 

 

Part I. - Financial Information

 3

 

 

  

Item 1.

Financial Statements.

3

 

 

  

 

Balance Sheets as of September 30, 2018 (unaudited) and December 31, 2017.

3

 

 

  

 

Statements of Operations for the Three and Nine Months ended September 30, 2018 and 2017 (unaudited).

4

 

 

  

 

Statements of Cash Flows for the Three and Nine Months ended September 30, 2018 and 2017 (unaudited).

5

 

 

  

 

Notes to Financial Statements (unaudited).

6

 

 

  

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations.

11

 

 

  

Item 3.

Quantitative and Qualitative Disclosure about Market Risk.

17

 

 

  

Item 4.

Controls and Procedures.

17

 

 

  

 

Part II. - Other Information

18

 

 

  

Item 1. 

Legal Proceedings.

18

 

  

  

Item 1A.

Risk Factors.

18

 

  

  

Item 2. 

Unregistered Sales of Equity Securities and Use of Proceeds.

18

 

  

  

Item 3. 

Defaults Upon Senior Securities.

18

  

  

  

Item 4. 

Mine Safety Disclosures.

18

  

  

  

Item 5. 

Other Information.

18

 

 

  

Item 6.

Exhibits.

19

 

 

  

Signatures

20

 

 

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1.     FINANCIAL STATEMENTS.

 

 

McorpCX, Inc.

Balance Sheets

 

   

September 30,

   

December 31,

 
   

2018

   

2017

 
   

(unaudited)

         

Assets

               

Current assets:

               

Cash and cash equivalents

  $ 1,469,921     $ 1,616,076  

Accounts receivable

    481,919       274,785  

Total current assets

    1,951,840       1,890,861  

Long term assets:

               

Property and equipment, net

    89,576       86,551  

Capitalized software development costs, net

    156,199       301,574  

Intangible assets, net

    -       6,250  

Other assets

    62,496       27,137  

Total assets

  $ 2,260,111     $ 2,312,373  
                 

Liabilities and Shareholders' Equity

               

Liabilities:

               

Accounts payable

  $ 481,691     $ 218,107  

Deferred revenue

    68,343       80,057  

Other current liabilities

    2,150       -  

Notes payable

    -       8,169  

Total current liabilities

    552,184       306,333  

Total liabilities

    552,184       306,333  

Shareholders' equity:

               

Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at September 30, 2018 and December 31, 2017

    -       -  

Additional paid-in capital

    6,439,846       6,428,997  

Accumulated deficit

    (4,731,919 )     (4,422,957 )

Total shareholders' equity

    1,707,927       2,006,040  

Total liabilities and shareholders' equity

  $ 2,260,111     $ 2,312,373  

 

The accompanying notes are an integral part of these unaudited financial statements.

 

3

 

 

 

McorpCX, Inc.

Statements of Operations

(unaudited)

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2018

   

2017

   

2018

   

2017

 
                                 

Revenue, net

                               

Consulting services

  $ 772,081     $ 539,562     $ 2,567,153     $ 1,304,541  

Products and other

    161,755       107,874       385,191       242,799  

Total revenue, net

    933,836       647,436       2,952,344       1,547,340  

Cost of goods sold

                               

Labor

    407,421       146,030       1,120,502       325,482  

Products and other

    215,007       120,055       540,130       320,577  

Total cost of goods sold

    622,428       266,085       1,660,632       646,059  

Gross profit

    311,408       381,351       1,291,712       901,281  

Expenses

                               

Salaries and wages

    251,111       214,923       684,029       713,363  

Contract services

    47,202       4,758       161,453       35,468  

Other general and administrative

    262,851       166,139       749,612       485,357  

Total expenses

    561,164       385,820       1,595,094       1,234,188  
                                 

Net operating loss

    (249,756 )     (4,469 )     (303,382 )     (332,907 )
                                 

Interest expense

    (645 )     (2,449 )     (1,048 )     (8,191 )
                                 

Other expense

    (3,775 )     (3,777 )     (4,532 )     (783 )
                                 

Loss before income taxes

    (254,176 )     (10,695 )     (308,962 )     (341,881 )
                                 

Income tax provision

    -       -       -       -  
                                 

Net loss

  $ (254,176 )   $ (10,695 )   $ (308,962 )   $ (341,881 )
                                 

Net loss per share-basic and diluted

  $ (0.01 )   $ (0.00 )   $ (0.02 )   $ (0.02 )
                                 

Weighted average common shares outstanding-basic and diluted

    20,426,158       20,426,158       20,426,158       20,426,158  

 

The accompanying notes are an integral part of these unaudited financial statements.

 

4

 

 

 

McorpCX, Inc.

Statements of Cash Flows

(unaudited)

 

   

Nine Months Ended September 30,

 
   

2018

   

2017

 

CASH FLOWS FROM OPERATING ACTIVITIES:

               

Net loss

  $ (308,962 )   $ (341,881 )

Adjustments to reconcile net loss to net cash used in operations:

               

Depreciation and amortization

    153,074       169,658  

Stock compensation expense

    10,849       88,111  

Loss on disposal of assets

    -       298  

Unrealized loss (gain) on foreign currency transactions

    -       (2,149 )

Changes in operating assets and liabilities:

               

Accounts receivable

    (207,134 )     (147,878 )

Other assets

    (35,359 )     (2,854 )

Accounts payable

    263,584       98,853  

Other current liabilities

    2,150       2,183  

Deferred revenue

    (11,714 )     (12,282 )
                 

Net cash used in operating activities

    (133,512 )     (147,941 )
                 

INVESTING ACTIVITIES

               

Equipment purchases

    (4,474 )     (2,353 )

Proceeds from sale of equipment

    -       2,000  

Capitalized software development costs

    -       (93,803 )
                 

Net cash used in investing activities

    (4,474 )     (94,156 )
                 

FINANCING ACTIVITIES

               

Repayment of notes payable

    (8,169 )     -  
                 

Net cash used in financing activities

    (8,169 )     -  
                 

Decrease in cash and cash equivalents

    (146,155 )     (242,097 )
                 

Cash and cash equivalents, beginning of period

    1,616,076       1,925,744  
                 

Cash and cash equivalents, end of period

  $ 1,469,921     $ 1,683,647  
                 

Supplemental disclosure of cash flow information:

               

Interest paid

  $ 1,048     $ 5,966  

 

The accompanying notes are an integral part of these unaudited financial statements.

  

5

 

 

MCORPCX, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

(unaudited)

  

 

 

Note 1: Organization and Basis of Presentation

 

McorpCX, Inc. (“we,” “us,” “our,” or the “Company”) was incorporated in the State of California on December 14, 2001. We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue.

 

We are a customer experience services company, delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand “cloud based” customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization.

 

The financial statements and related disclosures as of and for the three and nine months ended September 30, 2018 and 2017, are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The balance sheet as of December 31, 2017 was derived from the audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2017. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These financial statements should be read in conjunction with the financial statements included in our Annual Report for the year ended December 31, 2017, filed on Form 10-K with the SEC on March 29, 2018.  The results of operations for the three and nine months ended September 30, 2018, are not necessarily indicative of the results to be expected for the full year. Unless the context otherwise requires, all references to "McorpCX," "we," "us," "our" or the "Company" are to McorpCX, Inc.

 

 

 

Note 2: Recent Accounting Pronouncements

 

In January 2017, the FASB issued ASU No. 2017-03, Accounting Changes and Error Corrections (Topic 250) and Investments—Equity Method and Joint Ventures (Topic 323). The ASU adds SEC disclosure requirements for both the quantitative and qualitative impacts that certain recently issued accounting standards will have on the financial statements of a registrant when such standards are adopted in a future period. Specially, these disclosure requirements apply to the adoption of ASU No. 2014- 09,; ASU No. 2016-02, Leases (Topic 842); and ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. In addition, ASU No. 2017-03 conforms certain paragraphs within the SEC Staff Guidance to the guidance issued in Accounting Standards Update No. 2014-01, Investments—Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Qualified Affordable Housing Projects. The Company is currently evaluating the impact of these amendments on its financial statements.

 

In May 2017, the FASB issued ASU No. 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting, to provide clarity and reduce both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, Compensation—Stock Compensation, to a change to the terms or conditions of a share-based payment award. The ASU provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in ASC 718. The amendments are effective for fiscal years beginning after December 15, 2017 and should be applied prospectively to an award modified on or after the adoption date. Early adoption is permitted, including adoption in an interim period. The Company adopted ASU 2017-09 with no material impact to the financial statements.

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (Topic 606) "Revenue from Contracts with Customers." Topic 606 supersedes the revenue recognition requirements in Topic 605 “Revenue Recognition” (Topic 605) and requires entities to recognize revenue when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We adopted Topic 606 as of January 1, 2018 using the modified retrospective transition method. See Note 3 for further details.

 

In November 2017, the FASB issued ASU No. 2017-14, Income Statement—Reporting Comprehensive Income (Topic 220), Revenue Recognition (Topic 605), and Revenue from Contracts with Customers (Topic 606) (SEC Update). The ASU amends SEC paragraphs pursuant to the SEC Staff Accounting Bulletin No. 116 and SEC Release No. 33-10403, which bring existing guidance into conformity with Topic 606, Revenue from Contracts with Customers. The amendments were effective upon issuance. The Company has evaluated the impact on revenue recognition and does not expect these amendments to have a material effect on its financial statements.

 

6

 

 

In February 2018, the FASB issued ASU No. 2018-03, Technical Corrections and Improvements to Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which retained the current framework for accounting for financial instruments in generally accepted accounting principles (GAAP) but made targeted improvements to address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The amendments in this Update are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years beginning after June 15, 2018. The Company adopted ASU 2018-03 with no material impact to the financial statements.

 

In February 2018, the FASB issued ASU No. 2018-02, Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC 220, Income Statement — Reporting Comprehensive Income, to “allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.” In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU No. 2018-02 on its consolidated financial statements.

 

 

 

Note 3. Revenues

 

Adoption of ASC Topic 606, "Revenue from Contracts with Customers"

 

On January 1, 2018 we adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Topic 605.

 

We did not have a cumulative impact as of January 1, 2018 due to the adoption of Topic 606 and there was not an impact to our statements of operations for the three and nine months ended September 30, 2018 as a result of applying Topic 606.

 

Revenue Recognition

 

The Company’s revenue consists primarily of professional and consulting services, as well as reimbursable expenses billed to clients, software-enabled product sales and other revenues. Consulting services include customer experience management consulting in the areas of strategy development, planning, education, training and program design, and includes the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. Product revenue is from productized and software-enabled service sales not elsewhere classified, while other revenue includes reimbursement of related travel costs and out-of-pocket expenses.

 

The consulting services are contracted under master terms and conditions with statements of work (“SOW”) defined for each project. A typical consulting SOW will span a period of 60-180 days and will usually be billed to the client based on certain milestones being achieved throughout the SOW. The Company recognizes revenue based upon a percentage of completion of each SOW during each project, which are typically 60-180 days in duration. In addition, we typically incur travel other miscellaneous expenses during work on each SOW which we bill to our clients for reimbursement. The travel and miscellaneous expenses are recognized in revenue on a percentage of work complete basis.

 

Contract costs, such as commissions, are typically incurred contemporaneously with the pattern of revenue recognition and, as such, are expensed as incurred.

 

Consulting Service Revenues

 

The Company’s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the customer experience being analyzed. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has no alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract.

 

7

 

 

Product and other revenue

  

Product and other revenue during 2018 has primarily been derived from reimbursable expenses charged to clients and to a lesser degree from product sales and related revenue.  The product related portion of this revenue originates from the utilization of the Company’s web-hosted Touchpoint Mapping On-Demand application (“Touchpoint Mapping”), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services.  Customer licenses for Touchpoint Mapping are not subject to the licensing guidance in Topic 606 because the customer can’t take possession of the software at any time and the customer would not be able to operate the software on its own or with another third party. Fees charged to customers of Touchpoint Mapping may include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company’s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does not affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do not unbundle such services into separate performance obligations as their pattern of transfer does not differ.

 

The aggregate amount of the fees received from customers that are allocated to product and other revenue performance obligations that are unsatisfied (or partially unsatisfied) as of September 30, 2018 is $68,343 and included in deferred revenue on the accompanying balance sheet. The Company expects to recognize revenue of $68,343 in the next 12 months related to these unsatisfied (or partially unsatisfied) performance obligations. Revenue related to these performance obligations are not expected to be recognized beyond fiscal year 2018. 

 

Arrangements with Multiple Performance Obligations

 

The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers. If the pattern of transfer of control for each obligation does not differ, the Company does not allocate revenue to specific performance obligations.

 

Deferred Revenues (Contract Liabilities)

 

The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.

 

Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is not significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer.

 

During the nine months ended September 30, 2018, we recognized revenue of $80,057, related to our contract liabilities included in deferred revenue at December 31, 2017. During the nine months ended September 30, 2017 we recognized revenue of $51,029, related to our contract liabilities included in deferred revenue at December 31, 2016. There was no revenue recognized for the three months ended September 30, 2018 or 2017 related to deferred revenue balances for December 31, 2017 and 2016, respectively.

  

Contract Assets

 

Given the nature of the Company’s services and contracts, it has no contract assets.

 

Practical Expedients and Exemptions

 

Contract costs consist primarily of sales commissions, The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less and they are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses.

 

The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

 

8

 

 

 

Note 4: Capitalized Software Development Costs 

 

Costs incurred to develop Software as a Service (SaaS) technology consist of external direct costs of materials and services and payroll and payroll-related costs for employees who directly devote time to the project. Research and development costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when technological feasibility is established. Costs incurred during the operating stage of the software application relating to upgrades and enhancements are capitalized to the extent that they result in the extended life of the product. All other costs are expensed as incurred. Expenses relating to upgrades and enhancements were capitalized during the nine months ended September 30, 2017 in the amount of $93,803. There were no expenses capitalized during the nine months ended September 30, 2018.

 

Amortization of software development costs commenced when the product was available for general release to customers. The capitalized costs are amortized on a straight-line basis over the three-year expected useful life of the software. Capitalized software development costs, net of amortization, were $156,199 and $301,574 as of September 30, 2018 and December 31, 2017, respectively. Amortization expense incurred during the nine months ended September 30, 2018 and 2017 was $145,375 and $142,277, respectively and is included in cost of goods sold in the statements of operations.

  

 

 

Note 5: Intangible Assets

 

Intangibles consist of the following as of September 30, 2018.

 

   

2018

 
           

Accumulated

         
   

Gross

   

Amortization

   

Net Book Value

 

Website development costs

  $ 70,188     $ (70,188 )   $ -  

Media distribution rights

    25,000       (25,000 )     -  

Intellectual property

    5,000       (5,000 )     -  

LinkedIn Group

    2,500       (2,500 )     -  

Organization costs

    1,377       (1,377 )     -  

Total intangibles

  $ 104,065     $ (104,065 )   $ -  

 

Total amortization of intangible assets was $6,250 and $22,906 for the nine months ended September 30, 2018 and 2017, respectively.

 

 

Note 6: Stock-Based Compensation

 

In December 2015, we adopted a revised share option plan in which Plan Shares cannot exceed 10% of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a 10-year term. This share option plan was approved by the Company’s shareholders at the annual meeting of shareholders on August 10, 2016.

 

To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price.  The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin No. 110.  The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

 

At September 30, 2018, 1,350,000 stock options were exercisable and $10,849 of total compensation cost related to share-based compensation grants had been recognized for the nine months ended September 30, 2018. Unrecognized compensation expense from stock options was $116,226 at September 30, 2018, which is expected to be recognized over a weighted-average vesting period of 2.88 years beginning October 1, 2018.

 

9

 

 

The following table summarizes our stock option activity for the nine months ended September 30, 2018:

 

                   

Weighted

         
           

Weighted

   

Average

         
           

Average

   

Remaining

   

Aggregate

 
   

Number of

   

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term (in years)

   

Value

 

Outstanding at December 31, 2017

    1,350,000     $ 0.60       6.07       -  

Granted

    700,000       0.23       6.00       -  

Exercised

    -       -       -       -  

Forfeited or expired

    -       -       -       -  

Outstanding at September 30, 2018

    2,050,000     $ 0.47       6.88       -  

Exercisable at September 30, 2018

    1,350,000     $ 0.60       5.32     $ -  

 

During the nine months ended September 30, 2018, the Company granted 700,000 options to certain employees of the Company with an incremental vesting schedule over 3 years and a weighted-average grant date fair value of $0.17. Of the total options granted during the period 400,000 have a ten year term and 300,000 have a five year term. The following assumptions were used to calculate weighted average fair values of the options granted in the nine months ended September 30, 2018. There were no options granted during the nine months ended September 30, 2017. 

 
   

2018

 

Expected life (in years)

    3.50 - 6.00  

Risk-free interest rate

        2.79 %

Volatility

    139.34% - 162.16 %

Dividend yield

        -  

Weighted average grant date fair value per option granted

  $     0.17  

 

 

 

Note 7: Concentrations

 

We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune 500 companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the nine months ended September 30, 2018 and 2017, the percentage of sales and the concentrations are:

 

   

2018

   

2017

 

Largest client

    39 %     31 %

Second largest client

    28 %     17 %

Third largest client

    13 %     16 %

Next three largest clients

    15 %     23 %

All other clients

    5 %     13 %
      100 %     100 %

 

Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is no provision made to include an allowance for doubtful accounts.

   

 

 

Note 8: Debt

 

On September 16, 2011, a $100,000 CAD note was executed with an individual, a 1.86% shareholder. The note is structured to incur a balloon payment of the principal and 4% APR non-compounding accrued interest on its amended maturity date of October 31, 2017. Effective October 31, 2016 the note's previous maturity date of September 16, 2016 was amended to extend the maturity date to October 31, 2017. In October 2017, $66,217 was paid to the note holder and the remaining balance of $8,169 was paid in February 2018 fully satisfying the debt. The balance of $8,169 is presented under notes payable on the balance sheet as of December 31, 2017 and there were no fees or penalties incurred by the Company. There was no notes payable balance as of September 30, 2018. We have recorded a foreign currency loss of $911 and gain of $1,409 during the nine months ended September 30, 2018 and 2017, respectively, related to the revaluation of this note's principal from CAD to USD.

 

Interest expense was $1,048 and $8,191 for the nine months ended September 30, 2018 and 2017, respectively and consists of interest on our short-term promissory notes, and credit card balances.

   

 

 

Note 9: Going Concern

 

The accompanying financial statements and notes have been prepared assuming that the Company will continue as a going concern.

 

10

 

 

We have had material operating losses and have not yet created positive cash flows. These factors raise substantial doubt as to our ability to continue as a going concern. However, we continue to improve our core consulting services revenue and are seeking ways and have implemented plans to reduce operating cost in order to reduce our net operating losses. We believe that our increased revenues and improved net losses in the year ended December 31, 2017 and the nine months ended September 30, 2018 compared to our financial results for the nine months ended September 30, 2017 coupled with our cash balance of $1,469,921 at September 30, 2018 and our belief that sufficient funding may be available from private placements of equity securities or additional borrowings if needed will enable us to meet our liquidity needs over the next 12 months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing debt, nor that sufficient capital can be raised through debt or equity financing. The financial statements do not include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.

 

 

 

Note 10: Basic and Diluted Net Income / (Loss) per Share

 

The Company follows FASB ASC 260, “Earnings Per Share”, when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share. Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. For the three and nine months ended September 30, 2018 and 2017, the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net income (loss) per share basic and diluted are equal in all periods presented. Securities that were not included in the diluted per share calculations because they would be anti-dilutive were vested options to purchase common stock of 1,350,000 and 1,425,000 as of September 30, 2018 and 2017, respectively.

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2018

   

2017

   

2018

   

2017

 

Net loss

  $ (254,176

)

  $ (10,695

)

  $ (308,962

)

  $ (341,881

)

Basic and diluted weighted average common shares outstanding

    20,426,158       20,426,158       20,426,158       20,426,158  
                                 

Net loss per share, basic and diluted

  $ (0.01

)

  $ (0.00

)

  $ (0.02

)

  $ (0.02

)

 

 

 

Note 11: Related-Party Transactions

 

During the nine months ended September 30, 2018, a company controlled by the Company’s former Chief Executive Officer purchased from the Company an internet domain name that was obsolete and not being used in the business nor needed for the go-forward business for $2,000 that is included in other income (expense) on the statements of operations.

 

 

 

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Cautionary Statement

 

This Management’s Discussion and Analysis includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like: “believe,” “expect,” “plan”, “estimate,” “anticipate,” “intend,” “project,” “will,” “predicts,” “seeks,” “may,” “would,” “could,” “potential,” “continue,” “ongoing,” “should” and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this Form 10-Q. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or from our predictions. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise.

 

Unless the context otherwise requires, all references to "McorpCX," "we," "us," "our" or the "Company" are to McorpCX, Inc. and our subsidiaries.

 

Critical Accounting Policies and Estimates

 

Our financial statements are prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates. We believe that the assumptions and estimates associated with revenue recognition, income taxes, stock-based compensation, research and development costs and impairment of long-lived assets have the greatest potential impact on our financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

 

A description of the Company’s critical accounting policies and related judgments and estimates that affect the preparation of the Company’s financial statements is set forth in under the heading “Critical Accounting Policies and Estimates” in Item 7, Management’s Discussion and Analysis of the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. With the exception of the adoption of Topic 606 discussed in Note 3, such policies were unchanged during the nine months ended September 30, 2018.

 

11

 

 

Overview

 

We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. We believe that delivering better customer experiences is a powerful, sustainable way for any organization to differentiate themselves from their competition. As such, we are engaged in the business of providing customer experience focused consulting services and where applicable, delivering technology-enabled products and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities with the goal of helping them design and deliver better experiences for their customers.

 

Our primary source of revenue is derived from our consulting services which are intended to help primarily large and medium sized organizations plan, design and deliver better customer experiences in order to maximize their return on investment, improve efficiency, and increase the adoption of our products and services. Our services offered include a range of customer experience management consulting services in the areas of research, strategy development, planning, education, training and best practices, as well as providing customer-centric strategies and implementation roadmaps in support of these strategies.

 

Our products include on-demand “cloud based” customer experience management software such as Touchpoint Mapping® On-Demand (also marketed as McorpCX | Insights), referred to as “Touchpoint Mapping”, and McorpCX | Persona.

 

Touchpoint Mapping is a research-based online Software-as-a-Service (“SaaS”) solution designed to provide insights to organizations that can help them improve customer and employee experience, brand, and loyalty. It is designed to be a solution for customer-centric organizations to measure and gather customer data across all their touchpoints, channels and interactions with their customers.

 

McorpCX | Persona, another online SaaS solution, is designed for developing and managing customer persona, as well as automating the currently manual process of developing, managing and sharing persona across corporations. It is designed to help customer-centric businesses and the agencies and consultancies that serve them to better understand, connect with and serve their customers.

 

There are many potential unforeseen and significant market and competitive risks associated our current products and services. Though we released the first version of Touchpoint Mapping in 2013, and we released the first version of McorpCX | Persona in 2016, neither product has generated significant sales revenue to date, and we cannot predict the timing or probability of generating material sales revenue from either of them.

 

As of the date of this report, we have yet to engage the necessary sales and marketing staff or the capabilities required to identify, develop, and close material product sales opportunities, and currently lack sufficient resources to market and sell our products in the manner which we believe is required to achieve our product sales and revenue growth objectives. It is our expectation that numerous unforeseen challenges will be encountered as we continue to develop, market, distribute and sell our products and services.

 

Although management still believes that offering technology enabled consulting services can provide long-term profitability and we intend to continue to explore ways to successfully commercialize our software products, in the short-term, we are focused on expanding our consulting business which we believe may lead to greater revenues for the Company and which could be utilized for cross sale of technology products to our consulting clients. We intend to continue to evaluate our software products to determine the next phase of new product development and potential enhancements to our existing product suite or identify other software products that may be more conducive to supporting our CX consulting expertise.

 

The Company is in the process of determining the optimal path forward for our software products based on current market dynamics, the competitive environment and customer feedback. We continue to evaluate various potential strategies with the goal of improving our ability to achieve additional revenue and profit growth for both our software products as well as our consultant services. These possible strategies, which are generally focused on ways to create a more complete slate of customer experience solutions for our clients, include further software or technology development expenditures, pursuit of merger, acquisitions or joint ventures with companies that provide complimentary products and services, software licensing arrangements, and investment in additional infrastructure within our Company. Each of these possible strategies will be thoroughly vetted by our board of directors to assess the expected level of enterprise value creation for each strategy compared to the various risks associated with each possible scenario.  In addition, we may require financing to pursue these strategies that is beyond our current financial resources.  Accordingly, there is no assurance that we will be able to pursue any strategies that are identified by our board of directors.

 

We cannot assure you that we will be able to compete successfully against current or potential competitors, or that competition will not have a material adverse effect on our business, financial condition and operations.

 

12

 

 

Summary of Financial Results

 

Select financial highlights for the three and nine months ended September 30, 2018:

 

 

Total revenue increased by 44% from $647,436 during the third quarter of 2017 to $933,836 during the third quarter of 2018 and by 91% from $1,547,340 in the first nine months of 2017 to $2,952,344 in the first nine months of 2018.

 

 

 

 

We recorded net losses of $254,176 and $308,962 in the third quarter and first nine months of 2018, respectively, compared to net losses of $10,695 and $341,881 for the third quarter and first nine months of 2017.

 

 

 

 

The Company reported EBITDA(1) of ($204,478) and ($154,840) in the third quarter and first nine months of 2018, respectively, compared to $45,962 and ($164,032) in the third quarter and first nine months of 2017.

 

 

 

 

The Company had a cash balance of $1,469,921 at September 30, 2018 compared to a cash balance of $1,616,076 at December 31, 2017.

 

(1) We define EBITDA as net income (loss) plus interest, tax, depreciation and amortization expenses. We consider EBITDA to be a meaningful supplement to net income (loss) as a performance measure primarily because depreciation and amortization expenses are not actual cash costs, and interest and tax expenses are not related to our direct operating activities. See below for a reconciliation of net income (loss) to EBITDA.

 

Sources of Revenue

 

Our revenue consists primarily of professional and consulting services, reimbursable expenses billed to clients, and software-enabled product sales and other revenues. Consulting services include customer experience management consulting in the areas of strategy development, planning, education, training and program design, and includes the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. Product and other revenue during 2018 was principally related to revenue from reimbursement of expenses billed to clients and to a lesser degree from productized and software-enabled service sales.

 

Our current plan of operations is based on enhancing our consulting service revenue to open possible opportunities to cross-sell our third party licensed products to our clients in order to establish more recurring revenue. We anticipate that fees for professional and consulting services will remain our most significant revenue source in the foreseeable future. We have not obtained material stand-alone sales commitments for Touchpoint Mapping or McorpCX | Persona, and do not anticipate being able to do so until we engage the necessary sales and marketing staff to develop and execute product sales opportunities. During the second half of 2017, we stopped further development of our software in order to re-assess the product roadmap to better define the future direction of our software platform.

 

Cost of Goods Sold and General and Administrative Expenses

 

Cost of Goods Sold

 

Cost of goods sold has historically consisted primarily of expenses directly related to providing professional and consulting services. Those expenses include contract labor, third-party services, and materials and travel expenses related to providing professional services to our clients. Costs of goods also includes, but is not limited to, product-related hosting and monitoring costs, the cost of licenses for products embedded in the application, amortization of capitalized software development costs, service support costs, and costs related to account and subscription management.

  

General and Administrative Expenses

 

General and administrative expenses consist primarily of salary and related expenses for management, client delivery, finance and accounting, and sales and marketing. These expenses also include contract services, as well as marketing and promotion costs, professional fees, software license fee expenses, administrative costs, insurance, rent and a portion of travel expenses and other overhead, which are categorized as “other general and administrative expenses” in our financial statements. In addition, the other general and administrative expenses include the professional fees, filing, and registration costs necessary to meet the requirements associated with having to file reports with the United States Securities and Exchange Commission (“SEC”) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as well as having our stock listed on the TSX Venture Exchange (the “TSX-V”) in Canada and quoted on the OTCQB venture marketplace in the United States.

 

Sales and marketing expenses are currently reflected in salaries and wages, commissions, contract labor, sales, marketing and promotion, and other related overhead expense categories. Since we currently recognize revenue over the term of the subscriptions or professional services engagements, we expect to experience a delay between increases in selling and marketing expenses and the recognition of revenue. We expect to continue to incur significant sales and marketing expenses in both absolute dollars and as a percentage of expenses as we seek to increase the level of our sales and marketing activities. We expect that total general and administrative expenses will increase as we continue to add resources in connection with the growth of our business.

 

13

 

 

Results of Operations

 

                   

Change from

   

Percent Change

 

Revenue

 

2018

   

2017

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 933,836     $ 647,436     $ 286,400       44 %

Nine Months Ended September 30,

  $ 2,952,344     $ 1,547,340     $ 1,405,004       91 %

 

Overall, the 44% increase in total revenues for the three months ended September 30, 2018 compared to the same period in 2017 was attributed to a 43% increase in consulting services revenue as well as a 50% increase in products and other revenue for the three months ended September 30, 2018 compared to same period in the prior year.  The increase in products and other revenue was primarily the result of an increase in revenue from reimbursable expenses, which was partially offset by a decrease in product revenue. The increase in consulting services revenue from $539,562 for the three months ended September 30, 2017 to $772,081 for the same period in 2018 was primarily the result of increased revenues from both new clients as well as from existing clients in 2018 compared to 2017.  We have continued to improve upon our sales and marketing efforts which allowed us to attract new clients and cross-sell add-on services to our existing clients. Product and other revenue largely consisted of reimbursable expense income of $154,580 and $68,570 and only $7,175 and $39,304 in product revenue for the three months ended September 30, 2018 and 2017, respectively.  As such, the increase in product and other revenue from $107,874 for the three months ended September 30, 2017 to $161,755 for the same period in 2018 was attributed to a $86,010 increase in recognized revenue for reimbursable travel and miscellaneous expenses, which we provided in connection with our consulting services, being partially offset by a $32,129 decrease in product revenue during the current quarter compared to the same quarter in 2017.

 

Overall, the 91% increase in total revenues for nine months ended September 30, 2018 compared to the same period in 2017 was attributed to a 97% increase in consulting services revenue and a 59% increase in products and other revenue for the nine months ended September 30, 2018 compared to same period in the prior year. The increase in consulting services revenue from $1,304,541 for the nine months ended September 30, 2017 to $2,567,153 for the same period in 2018 was primarily the result of increased revenues from both new clients as well as from existing clients in 2018 compared to 2017.  We have continued to improve our sale and marketing efforts which allowed us to attract new clients and cross-sell add-on services to our existing clients. Product and other revenue largely consisted of reimbursable expense income of $362,979 and $151,973 and only $22,212 and $90,826 in product revenue for the three months ended September 30, 2018 and 2017, respectively.  As such, the increase in product and other revenue from $242,799 for the nine months ended September 30, 2017 to $385,191 for the same period in 2018 was attributed to a $211,006 increase in recognized revenue for reimbursable travel and miscellaneous expenses we provided in connection with our consulting services being partially offset by a $68,613 decrease in product revenue.

 

                   

Change from

   

Percent Change

 

Cost of Goods Sold

 

2018

   

2017

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 622,428     $ 266,085     $ 356,343       134 %

Nine Months Ended September 30,

  $ 1,660,632     $ 646,059     $ 1,014,573       157 %

 

Cost of goods sold increased by $356,343 and $1,014,573 for the three and nine months ended September 30, 2018, respectively, compared to the same periods in 2017 due primarily to increased resources required to support the increase in consulting services revenue provided during the three- and nine-month periods respectively. In the three and nine months ended September 30, 2018, our labor costs increased by $261,391 and $795,020 compared to the respective periods in the prior year mainly as a result of the Company’s need to contract outside services to assist with delivery of our consulting services in 2018. There was also an increase in reimbursable expenses of $91,919 and $202,866 for the three- and nine-month periods ended September 30, 2018 respectively compared to the same periods in the prior year, which was related to an increase in travel and miscellaneous expenses associated with the delivery of the increased consulting services in 2018.  The remaining increase was due to increases in other non-reimbursable expenses.

 

                   

Change from

   

Percent Change

 

Net Operating Income (Loss)

 

2018

   

2017

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ (249,756 )   $ (4,469 )   $ (245,287 )     5,489 %

Nine Months Ended September 30,

  $ (303,382 )   $ (332,907 )   $ 29,525       9 %

 

For the three months ended September 30, 2018, we had a net operating loss of $249,756 compared to a net operating loss of $4,469 for the three months September 30, 2017. The increase in net operating loss in the current quarter was primarily a result of increased labor costs combined with increased operating expenses, which more than offset increased total revenues in the third quarter of 2018 compared to the same quarter in 2017.  During the third quarter of 2018, we increased our revenues compared to the prior year period mostly as a result of certain large projects having very short sales cycles, coupled with the completion of some uniquely complex projects.  To ensure that we could complete these projects, we were required to utilize some short-term, higher expense third-party resources which increased our labor costs and therefore reduced our profitability.  This increased cost of resources was the primary driver of the 18% decrease in gross profit in the three months ended September 30, 2018 compared to the same period in the previous year. This reduction in gross profit margin coupled with higher administrative expenses also resulted in a net loss of $254,176 in the third quarter of 2018 compared to a net loss of $10,695 in the same quarter of 2017, as well as a decrease in EBITDA by $250,440 to a loss of $204,478 for the three months ended September 30, 2018 compared to a gain of $45,962 for the three months ended September 30, 2017.

 

For the nine months ended September 30, 2018 we had a net operating loss of $303,382 compared to a net operating loss of $332,907 for the nine months September 30, 2017. The decrease in net operating loss for the current period compared to the same period in 2017 was primarily a result of increased total revenues in the first nine months of 2018 compared to the same period in 2017 being partially offset by increased labor costs combined with increased operating expenses in the current year period compared to the prior year period. During 2018, we focused on growing our consulting services operations through increased business development activities which resulted in a 43% increase in gross profit for the nine months ended 2018 compared to the same period in the previous year. Net loss decreased to $308,962 in the first nine months of 2018 compared to a net loss of $341,881 in the same period of 2017, while EBITDA improved slightly by $9,192 to a loss of $154,840 for the nine months ended September 30, 2018 compared to a loss of $164,032 for the nine months ended September 30, 2017. 

  

14

 

 

We consider EBITDA to be a meaningful supplement to net income (loss) as a performance measure primarily because depreciation and amortization expenses are not an actual cash costs, and interest and tax expenses are not related to our direct operating activities. In addition, we believe EBITDA is commonly used by investors and other interested parties to evaluate our financial performance. EBITDA does not reflect the impact of a number of items that affect our net income (loss), including financing costs. EBITDA should not be considered as an alternative to net income (loss) or income (loss) from operations as a measure of performance, or as an alternative to net cash from operating activities as a measure of liquidity. EBITDA is an internal measure and therefore may not be comparable to other companies. EBITDA has significant limitations as an analytical tool, and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are that EBITDA does not reflect: (i) our cash expenditures, or future requirements, for capital expenditures or contractual commitments; (ii) changes in, or cash requirements for, working capital needs; and (iii) the interest expense, or the cash requirements necessary to service interest or principal payments, on our outstanding debt (if any). Because of these limitations, EBITDA should only be considered as a supplemental performance measure and should not be considered as a measure of liquidity or cash available to us to invest in the growth of our business. Because all companies do not calculate EBITDA in the same manner, EBITDA as calculated by us may differ from EBITDA as calculated by other companies. We compensate for these limitations by using EBITDA as a supplemental measure of our performance and by relying primarily on our GAAP financial statements.

 

The following table provides a reconciliation of net income (loss) to EBITDA for the periods indicated:

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2018

   

2017

   

2018

   

2017

 
                                 

Net Income (Loss)

  $ (254,176 )   $ (10,695 )   $ (308,962 )   $ (341,881 )

Depreciation and Amortization

    (49,053 )     (54,208 )     (153,074 )     (169,658 )

Interest expense

    (645 )     (2,449 )     (1,048 )     (8,191 )
                                 

EBITDA

  $ (204,478 )   $ 45,962     $ (154,840 )   $ (164,032 )

 

 

                   

Change from

   

Percent Change

 

Salaries and Wages

 

2018

   

2017

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 251,111     $ 214,923     $ 36,188       17 %

Nine Months Ended September 30,

  $ 684,029     $ 713,363     $ (29,334 )     (4 %)

 

Salaries and wages increased by $36,188 during the three months ended September 30, 2018 compared to the same period in 2017 mostly as a result of an increase in salaries of $19,300, an increase of $6,200 in payroll taxes, and an increase of $15,600 in commissions offset partially by a $4,900 reduction in stock-based compensation expense primarily related to certain options forfeited late in 2017.

 

Salaries and wages decreased by $29,334 during the nine months ended September 30, 2018 compared to the same period in 2017 mostly as a result of a decrease in stock-based compensation expense of approximately $77,300, which was primarily driven by the Company not granting options to employees until later in 2018 as well as a number of options forfeited in late 2017. Stock compensation expense was $10,849 and $88,111 for the nine months ended September 30, 2018 and 2017, respectively. These decreases are partially offset with an increase of $29,900 in salaries and a $2,400 increase in payroll taxes as well as an increase in commissions of $15,600 during the first nine months of 2018 compared to the same period in 2017. From the total officer’s salary costs incurred during the nine months ended September 30, 2017, $21,000 was capitalized.

 

15

 

 

We did not incur any software development costs for either the three or nine months ended September 30, 2018 primarily due to the decision to curtail additional software development halfway through 2017.

 

                   

Change from

   

Percent Change

 

Contract Services

 

2018

   

2017

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 47,202     $ 4,758     $ 42,444       892 %

Nine Months Ended September 30,

  $ 161,453     $ 35,468     $ 125,985       355 %

 

Contract services expenses increased during the three and nine months ended September 30, 2018 compared to the same periods in 2017 primarily due to increased accounting and administrative costs as well as other expenses associated with the additional personnel required to support increased consulting projects and from the contractor fees related to our Chief Financial Officer during the current quarter and first nine months of 2018 compared to the same periods in 2017.

 

                   

Change from

   

Percent Change

 

Other General and Administrative

 

2018

   

2017

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 262,851     $ 166,139     $ 96,712       58 %

Nine Months Ended September 30,

  $ 749,612     $ 485,357     $ 264,255       54 %

 

Other general and administrative costs increased for the three months ended September 30, 2018 compared to the same period in 2017 primarily due to an increase in sales and marketing expenses of $50,400 as well as an increase in professional and legal fees of $42,100 mostly due to increased accounting fees, legal fees, and other professional fees related to business development and corporate governance activities during the current quarter compared to the same period in 2017.

 

Other general and administrative costs increased for the nine months ended September 30, 2018 compared to the same period in 2017 primarily due to an increase in sales and marketing expenses of $134,400 as well as an increase in professional fees and legal fees of $143,700 mostly due to increased accounting fees associated with additional work related to the adoption of new accounting standard ASC 606 in January 2018, the year-over-year timing of incurring accounting fees, as well as an increase in legal fees and other professional fees related to business development and corporate governance activities during the current period compared to the same period in 2017. Computer and software expenses also increased by $18,200 compared to the same period in 2017.  These increases were partially offset by a $38,300 decrease in expenses related to administration, rent and utilities in the first nine months of 2018 compared to the same period in 2017. 

 

                   

Change from

   

Percent Change

 

Other Income/Expense

 

2018

   

2017

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ (3,775 )   $ (3,777 )   $ 2       (0 %)

Nine Months Ended September 30,

  $ (4,532 )   $ (783 )   $ (3,749 )     (479 %)

 

Other income (expense) increased for the nine months ended September 30, 2018 when compared to the corresponding period in 2017 primarily due to an increase in state use tax expenses.

 

Liquidity and Capital Resources

 

We measure our liquidity in a variety of ways, including the following:

 

   

September 30,

   

December 31,

 
   

2018

   

2017

 

Cash and cash equivalents

  $ 1,469,921     $ 1,616,076  

Working capital

  $ 1,399,656     $ 1,584,528  

 

16

 

 

Anticipated Uses of Cash

 

For the nine months ended September 30, 2018 and the year ended December 31, 2017, we were able to finance our operations, including capital expenditures for product development and marketing activities with cash generated through operating activities, and cash on hand. The accompanying financial statements have been prepared in accordance with GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.

 

In 2017 our primary area of investment was professional staff to support our consulting services, including client relationship management, software development costs during the first half of 2017 and staff for administration, sales and marketing activities.

 

During the first nine months of 2018, our primary uses of cash included cash paid to professional staff to support our consulting services, professional services along with our general and administrative support and new business development activities. It is currently anticipated that our primary uses of cash for the remainder of 2018 will closely mirror our uses of cash during the first nine months of 2018.

 

We currently plan to fund our expenditures with cash flows generated from ongoing operations and/or if needed, the possibility may exist to raise additional capital through debt financing and/or through sales of common stock. We do not intend to pay dividends in the foreseeable future. Based upon the current level of our pipeline of signed contracts and pipeline of potential new projects plus our current expectations for future periods in light of the current economic environment, we believe that cash flow from operations and available cash will be adequate to finance the capital requirements for our business during the next 12 months.

 

We continue to seek ways to expand upon our business and as such, in the future we may make acquisitions of businesses or assets or commitments to additional capital projects. To achieve the long-term goals of expanding our assets and earnings, including through acquisitions, capital resources may be required. Depending on the size of a transaction, the capital resources that may be required can be substantial. The necessary resources may be generated from cash flow from operations, cash on hand, borrowing against our assets or the issuance of securities, and there is no assurance these capital resources will be available to us when required.

 

Cash Flow – Nine months Ended September 30, 2018 and 2017

 

Operating Activities. Net cash used in operating activities decreased to $133,512 for the nine months ended September 30, 2018 compared to $147,941 for the nine months ended September 30, 2017, mostly as a result of increased cash from a reduction in net loss of $32,919 combined with a $164,731 increase in accounts payable during the current period compared to the same period of 2017, being partially offset by a $91,761 increase in accounts receivable and other assets as well as a reduction of the non-cash stock compensation expenses by $77,262, in the first nine months of 2018 compared to the first nine months of 2017.

 

Days Sales Outstanding (“DSO”), which the Company defines as the average number of days it takes to collect revenue once a sale has been made, increased in the first nine months of 2018 compared to the same period of the prior year. During the nine months ended September 30, 2018, DSO was approximately 45 days, up from approximately 31 days during the nine months ended September 30, 2017. The increase in DSO was mostly attributed to the timing of collections from clients which increased our accounts receivable balance at September 30, 2018 compared to September 30, 2017. In addition to the increased DSO, our accounts receivable increased largely due to the 44% and 91% increase in revenue during the three and nine months ended September 30, 2018, respectively. DSO can fluctuate due to the timing and nature of contracts that lead to up-front billings related to deferred revenue on services not yet performed.

 

Investing Activities. There was $4,474 net cash used in investing activities for the nine months ended September 30, 2018 compared to $94,156 in net cash used in investing activities for the same period in 2017. Net cash used in investing activities in 2017 primarily consisted of cash used for capitalized software development costs of $93,803 partially offset by proceeds from the sale of equipment.

 

Financing Activities. Net cash used in financing activities for the nine months ended September 30, 2018 amounted to $8,169 which related to the repayment of a $100,000 CAD note during the period. There was no cash provided by, or used in, financing activities for the nine months ended September 30, 2017.  

 

Off Balance Sheet Arrangements

 

We did not have any off-balance sheet arrangements as of September 30, 2018.

  

   

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

  

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and as such, are not required to provide the associated information under this item.

 

  

ITEM 4.

CONTROLS AND PROCEDURES.

 

Disclosure Controls and Procedure

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were not effective, as a result of the material weaknesses identified in connection with our financial statements as of December 31, 2017, as disclosed on our Form 10-K annual report for the year ended December 31, 2017.

 

17

 

 

Changes in Internal Controls

 

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. However, in order to address the deficiencies in the Company’s internal control over financial reporting, the Company engaged an external firm during 2018 to provide outsourced controller services and segregation of certain duties within the accounting function.

 

 

PART II. OTHER INFORMATION

 

 

ITEM 1.

LEGAL PROCEEDINGS.

 

We are not involved in any legal actions or claims and to our knowledge no such actions or claims are pending.

  

 

ITEM 1A.

RISK FACTORS.

 

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 (the “2017 Annual Report”), which could materially affect our business, results of operations or financial condition.

 

The risk factors affecting the Company have not materially changed as of September 30, 2018 from those disclosed in the 2017 Annual Report. However, it is important to note that the risks described in our 2017 Annual Report are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may eventually prove to materially adversely affect our business, results of operations or financial condition.

 

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Recent Sales of Unregistered Securities

 

There were no unregistered sales of our equity securities during the nine-month period ended on September 30, 2018.

 

Purchases of Equity Securities

 

During the nine months ended September 30, 2018, there were no purchases of our common stock made by, or on behalf of, the Company or any "affiliated purchaser," as defined by Rule 10b-18 of the Exchange Act.

  

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

None.

 

  

ITEM 4.

MINE SAFETY DISCLOSURES

 

Not applicable.

  

 

ITEM 5.

OTHER INFORMATION.

 

(a)

Not applicable.

 

18

 

 

ITEM 6.

EXHIBITS. 

 

3.1

Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.2

Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.3

Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.4

Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).

3.5

Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).

3.6 

Amended and Restated Bylaws (Incorporated by reference to Exhibit 3. 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on November 24, 2015).

31.1

Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).

31.2

Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).

32.1*

Certification of Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension – Schema

101.CAL

XBRL Taxonomy Extension – Calculations

101.DEF

XBRL Taxonomy Extension – Definitions

101.LAB

XBRL Taxonomy Extension – Labels

101.PRE

XBRL Taxonomy Extension – Presentation

 

*Furnished, not filed

 

Notes to Exhibits List:

 

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Balance Sheet, (ii) Statements of Operations, (iii) Statements of Cash Flows, and (iv)Notes to the Financial Statements. In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be part of any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

19

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report has been signed on its behalf by the undersigned, thereunto duly authorized on this 14th day of November 2018.

 

 

MCORPCX, INC.

 

 

 

 

 

BY:

/s/Gregg Budoi

 

 

Gregg Budoi

 

 

Chief Executive Officer

  

  

  

  

BY:

/s/Tricia Tomko

  

 

Tricia Tomko

  

 

Chief Financial Officer

 

20

 

 

EXHIBIT INDEX

 

3.1

Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.2

Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.3

Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.4

Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).

3.5

Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).

3.6 

Amended and Restated Bylaws (Incorporated by reference to Exhibit 3. 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on November 24, 2015).

31.1

Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).

31.2

Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).

32.1*

Certification of Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension - Schema

101.CAL

XBRL Taxonomy Extension - Calculations

101.DEF

XBRL Taxonomy Extension - Definitions

101.LAB

XBRL Taxonomy Extension - Labels

101.PRE

XBRL Taxonomy Extension - Presentation

 

*Furnished, not filed

 

Notes to Exhibits List:

 

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Balance Sheet, (ii) Statements of Operations, (iii) Statements of Cash Flows, and (iv)Notes to the Financial Statements. In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be part of any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

21

EX-31.1 2 ex_129508.htm EXHIBIT 31.1 ex_129508.htm

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Gregg Budoi, certify that:

 

1.

I have reviewed this Form 10-Q for the period ended September 30, 2018 of McorpCX, Inc.;

 

  

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  

  

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  

  

  

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  

  

  

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  

  

  

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  

  

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  

  

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  

  

  

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:

November 14, 2018

/s/Gregg Budoi

  

  

Gregg Budoi

  

  

Principal Executive Officer

 

EX-31.2 3 ex_129509.htm EXHIBIT 31.2 ex_129509.htm

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

 

I, Tricia Tomko, certify that:

 

1.

I have reviewed this Form 10-Q for the period ended September 30, 2018 of McorpCX, Inc.;

 

  

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  

  

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  

  

  

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  

  

  

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  

  

  

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  

  

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  

  

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  

  

  

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:

November 14, 2018

/s/Tricia Tomko

  

  

Tricia Tomko

  

  

Principal Financial Officer

  

EX-32.1 4 ex_129510.htm EXHIBIT 32.1 ex_129510.htm

Exhibit 32.1 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report of McorpCX, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregg Budoi, Chief Executive Officer of the Company and Tricia Tomko, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

      

 

(2)

The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated this 14th day of November 2018.

 

 

  

/s/Gregg Budoi

  

Gregg Budoi

  

Chief Executive Officer

  

  

  

/s/Tricia Tomko

  

Tricia Tomko

  

Chief Financial Officer

 

EX-101.INS 5 mccx-20180930.xml XBRL INSTANCE DOCUMENT false --12-31 Q3 2018 2018-09-30 10-Q 0001535079 20426158 Yes false Non-accelerated Filer McorpCX, Inc. true mccx P3Y -93803 0.0186 P60D P180D 481691 218107 481919 274785 6439846 6428997 10849 0 6250 22906 1350000 1425000 2260111 2312373 1951840 1890861 93803 0 145375 142277 156199 301574 1469921 1616076 1925744 1683647 -146155 -242097 0 0 500000000 500000000 20426158 20426158 20426158 20426158 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7:</div> Concentrations</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500</div> companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the percentage of sales and the concentrations are:</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Second largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Third largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Next three largest clients</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">All other clients</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td> </tr> </table> </div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> provision made to include an allowance for doubtful accounts.</div></div> 0.39 0.31 0.28 0.17 0.13 0.16 0.15 0.23 0.05 0.13 1 1 0 68343 80057 80057 51029 0 0 407421 146030 1120502 325482 215007 120055 540130 320577 622428 266085 1660632 646059 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8:</div> Debt</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 16, 2011, </div>a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$100,000</div> CAD note was executed with an individual, a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.86%</div> shareholder. The note is structured to incur a balloon payment of the principal and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4%</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> APR </div>non-compounding accrued interest on its amended maturity date of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 31, 2017. </div>Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 31, 2016 </div>the note's previous maturity date of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 16, 2016 </div>was amended to extend the maturity date to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 31, 2017. </div>In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$66,217</div> was paid to the note holder and the remaining balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,169</div> was paid in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2018 </div>fully satisfying the debt. The balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,169</div> is presented under notes payable on the balance sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and there were&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> fees or penalties incurred by the Company. There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> notes payable balance as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018. </div>We have recorded a foreign currency loss of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$911</div> and gain of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,409</div> during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively, related to the revaluation of this note's principal from CAD to USD.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Interest expense was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,048</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,191</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively and consists of interest on our short-term promissory notes, and credit card balances.</div></div> 100000 0 0.04 153074 169658 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6:</div> Stock-Based Compensation</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2015, </div>we adopted a revised share option plan in which Plan Shares cannot exceed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-year term. This share option plan was approved by the Company&#x2019;s shareholders at the annual meeting of shareholders on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 10, 2016.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price.&nbsp; The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110.</div>&nbsp; The risk-free interest rate for periods within the contractual life of the option is based on the U.S.&nbsp;Treasury yield curve in effect at the time of grant.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div> stock options were exercisable and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10,849</div> of total compensation cost related to share-based compensation grants had been recognized for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018. </div>Unrecognized compensation expense from stock options was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$116,226</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>which is expected to be recognized over a weighted-average vesting period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.88</div> years beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2018.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 22.5pt;text-align:left;">&nbsp;</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The following table summarizes our stock option activity for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018:</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div> <table style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Aggregate</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Contractual</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Intrinsic</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Term (in years)</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Value</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2017</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.60</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.07</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">700,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.23</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited or expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at September 30, 2018</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,050,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.47</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.88</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at September 30, 2018</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.60</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.32</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>the Company granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">700,000</div> options to certain employees of the Company with an incremental vesting schedule over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> years and a weighted-average grant date fair value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.17</div>.</div> Of the total options granted during the period <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">400,000</div> have a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> year term and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">300,000</div> have a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> year term. The following assumptions were used to calculate weighted average fair values of the options granted in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018. </div>There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> options granted during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017.&nbsp;</div></div> &nbsp; <div> <table style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="4" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0); width: 154%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expected life (in years)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.50</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.79</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Volatility</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">139.34%</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">162.16</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Dividend yield</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average grant date fair value per option granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.17</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> -0.01 0 -0.02 -0.02 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10:</div></div> <div style="display: inline; font-weight: bold;">Basic and Diluted Net Income / (Loss) per Share</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company follows FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260,</div> &#x201c;Earnings Per Share&#x201d;, when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share. Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share &#x2013; basic and diluted. The share options were anti-dilutive due to the Company&#x2019;s net loss or the Company&#x2019;s common stock average market price was less than the share options exercise price. Accordingly, net income (loss) per share basic and diluted are equal in all periods presented. Securities that were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the diluted per share calculations because they would be anti-dilutive were vested options to purchase common stock of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,425,000</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div> <table style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(254,176</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10,695</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(308,962</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(341,881</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Basic and diluted weighted average common shares outstanding</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss per share, basic and diluted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> </table> </div></div> P2Y321D 116226 70188 25000 5000 2500 1377 104065 70188 25000 5000 2500 1377 104065 2149 911 1409 -298 262851 166139 749612 485357 311408 381351 1291712 901281 0 -254176 -10695 -308962 -341881 263584 98853 207134 147878 -11714 -12282 2150 2183 35359 2854 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5:</div> Intangible Assets</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Intangibles consist of the following as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Accumulated</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Gross</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amortization</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Net Book Value</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Website development costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">70,188</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(70,188</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Media distribution rights</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(25,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Intellectual property</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">LinkedIn Group</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Organization costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,377</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,377</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 36pt;">Total intangibles</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">104,065</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(104,065</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Total amortization of intangible assets was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6,250</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$22,906</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively.</div></div> 6250 645 2449 1048 8191 -1048 -8191 1048 5966 552184 306333 2260111 2312373 552184 306333 -8169 -4474 -94156 -133512 -147941 -308962 -341881 -254176 -10695 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2:</div> Recent Accounting Pronouncements</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03,</div> Accounting Changes and Error Corrections (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250</div>) and Investments&#x2014;Equity Method and Joint Ventures (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323</div>). The ASU adds SEC disclosure requirements for both the quantitative and qualitative impacts that certain recently issued accounting standards will have on the financial statements of a registrant when such standards are adopted in a future period. Specially, these disclosure requirements apply to the adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>- <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,;</div> ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>); and ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> Financial Instruments&#x2014;Credit Losses (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">326</div>): Measurement of Credit Losses on Financial Instruments. In addition, ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03</div> conforms certain paragraphs within the SEC Staff Guidance to the guidance issued in Accounting Standards Update <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> Investments&#x2014;Equity Method and Joint Ventures (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323</div>): Accounting for Investments in Qualified Affordable Housing Projects. The Company is currently evaluating the impact of these amendments on its financial statements.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> Compensation&#x2014;Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>): Scope of Modification Accounting, to provide clarity and reduce both (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) diversity in practice and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) cost and complexity when applying the guidance in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718,</div> Compensation&#x2014;Stock Compensation, to a change to the terms or conditions of a share-based payment award. The ASU provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718.</div> The amendments are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017 </div>and should be applied prospectively to an award modified on or after the adoption date. Early adoption is permitted, including adoption in an interim period. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> material impact to the financial statements.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the FASB issued Accounting Standards Update <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>) "Revenue from Contracts with Customers." Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> supersedes the revenue recognition requirements in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605</div> &#x201c;Revenue Recognition&#x201d; (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605</div>) and requires entities to recognize revenue when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We adopted Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>using the modified retrospective transition method. See&nbsp;Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>&nbsp;for further details.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,</div> Income Statement&#x2014;Reporting Comprehensive Income (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">220</div>), Revenue Recognition (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605</div>), and Revenue from Contracts with Customers (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>) (SEC Update). The ASU amends SEC paragraphs pursuant to the SEC Staff Accounting Bulletin <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">116</div> and SEC Release <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10403,</div> which bring existing guidance into conformity with Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> Revenue from Contracts with Customers. The amendments were effective upon issuance. The Company has evaluated the impact on revenue recognition and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect these amendments to have a material effect on its financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 15pt;text-align:justify;">&nbsp;</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03,</div> Technical Corrections and Improvements to Financial Instruments &#x2014; Overall (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">825</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>): Recognition and Measurement of Financial Assets and Financial Liabilities, which retained the current framework for accounting for financial instruments in generally accepted accounting principles (GAAP) but made targeted improvements to address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The amendments in this Update are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within those fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 15, 2018. </div>The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">03</div> with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> material impact to the financial statements.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">220,</div> Income Statement &#x2014; Reporting Comprehensive Income, to &#x201c;allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.&#x201d; In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> on its consolidated financial statements.</div></div> 0 8169 561164 385820 1595094 1234188 -249756 -4469 -303382 -332907 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1:</div> Organization and Basis of Presentation</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">McorpCX, Inc. (&#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; or the &#x201c;Company&#x201d;) was incorporated in the State of California on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 14, 2001. </div>We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">We are a customer experience services company, delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand &#x201c;cloud based&#x201d; customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The financial statements and related disclosures as of and for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The balance sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>was derived from the audited financial statements included in our Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These financial statements should be read in conjunction with the financial statements included in our Annual Report for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>filed on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K with the SEC on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 29, 2018.&nbsp; </div>The results of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results to be expected for the full year. Unless the context otherwise requires, all references to "McorpCX," "we," "us," "our" or the "Company" are to McorpCX, Inc.</div></div> 62496 27137 2150 -3775 -3777 -4532 -783 4474 2353 2000 47202 4758 161453 35468 89576 86551 2000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11:</div> Related-Party Transactions</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>a company controlled by the Company&#x2019;s former Chief Executive Officer purchased from the Company an internet domain name that was obsolete and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> being used in the business nor needed for the go-forward business for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,000</div> that is included in other income (expense) on the statements of operations.</div></div> 66217 8169 8169 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4:</div> Capitalized Software Development Costs</div>&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Costs incurred to develop Software as a Service (SaaS) technology consist of external direct costs of materials and services and payroll and payroll-related costs for employees who directly devote time to the project. Research and development costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when technological feasibility is established. Costs incurred during the operating stage of the software application relating to upgrades and enhancements are capitalized to the extent that they result in the extended life of the product. All other costs are expensed as incurred. Expenses relating to upgrades and enhancements were capitalized during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$93,803.</div> There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> expenses capitalized during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Amortization of software development costs commenced when the product was available for general release to customers. The capitalized costs are amortized on a straight-line basis over the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-year expected useful life of the software. Capitalized software development costs, net of amortization, were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$156,199</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$301,574</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>respectively. Amortization expense incurred during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$145,375</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$142,277,</div> respectively and is included in cost of goods sold in the statements of operations.</div></div> -4731919 -4422957 772081 539562 2567153 1304541 161755 107874 385191 242799 933836 647436 2952344 1547340 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div>&nbsp;Revenues</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Adoption of ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> "Revenue from Contracts with Customers"</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">On&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> we adopted Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> using the modified retrospective method applied to those contracts which were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> completed as of&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> Results for reporting periods beginning after&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>&nbsp;are presented under Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> while prior period amounts are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> adjusted and continue to be reported in accordance with our historic accounting under Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">We did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a cumulative impact as of&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>&nbsp;due to the adoption of Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> and there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> an impact to our statements of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018&nbsp;</div>as a result of applying Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606.</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Revenue Recognition</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company&#x2019;s revenue consists primarily of professional and consulting services, as well as reimbursable expenses billed to clients, software-enabled product sales and other revenues. Consulting services include customer experience management consulting in the areas of strategy development, planning, education, training and program design, and includes the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. Product revenue is from productized and software-enabled service sales <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> elsewhere classified, while other revenue includes reimbursement of related travel costs and out-of-pocket expenses.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The consulting services are contracted under master terms and conditions with statements of work (&#x201c;SOW&#x201d;) defined for each project. A typical consulting SOW will span a period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">180</div> days and will usually be billed to the client based on certain milestones being achieved throughout the SOW. The Company recognizes revenue based upon a percentage of completion of each SOW during each project, which are typically <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">180</div> days in duration. In addition, we typically incur travel other miscellaneous expenses during work on each SOW which we bill to our clients for reimbursement. The travel and miscellaneous expenses are recognized in revenue on a percentage of work complete basis.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Contract costs, such as commissions, are typically incurred contemporaneously with the pattern of revenue recognition and, as such, are expensed as incurred.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Consulting Service Revenues</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company&#x2019;s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the customer experience being analyzed. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 15pt;text-align:justify;">&nbsp;</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Product and other revenue</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Product and other revenue during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> has primarily been derived from reimbursable expenses charged to clients and to a lesser degree from product sales and related revenue.&nbsp; The product related portion of this revenue originates from the utilization of the Company&#x2019;s web-hosted Touchpoint Mapping On-Demand application (&#x201c;Touchpoint Mapping&#x201d;), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services.&nbsp; Customer licenses for Touchpoint Mapping are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> subject to the licensing guidance in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> because the customer can&#x2019;t take possession of the software at any time and the customer would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be able to operate the software on its own or with another <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party. Fees charged to customers of Touchpoint Mapping <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company&#x2019;s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> unbundle such services into separate performance obligations as their pattern of transfer does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> differ.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The aggregate amount of the fees received from customers that are allocated to product and other revenue performance obligations that are unsatisfied (or partially unsatisfied) as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$68,343</div> and included in deferred revenue on the accompanying balance sheet. The Company expects to recognize revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$68,343</div> in the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months related to these unsatisfied (or partially unsatisfied) performance obligations. Revenue related to these performance obligations are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to be recognized beyond fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div>&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Arrangements with Multiple Performance Obligations</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company&#x2019;s contracts with customers <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include multiple performance obligations. For such arrangements, the Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers. If the pattern of transfer of control for each obligation does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> differ, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> allocate revenue to specific performance obligations.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Deferred Revenues (Contract Liabilities)</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>we recognized revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$80,057,</div> related to our contract liabilities included in deferred revenue at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>we recognized revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$51,029,</div> related to our contract liabilities included in deferred revenue at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016. </div>There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> revenue recognized for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> related to deferred revenue balances for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;<div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Contract Assets</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Given the nature of the Company&#x2019;s services and contracts, it has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> contract assets.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Practical Expedients and Exemptions</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Contract costs consist primarily of sales commissions, The Company generally expenses sales commissions when incurred because the amortization period would have been <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less and they are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 15pt;text-align:left;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> 68343 68343 P1Y 251111 214923 684029 713363 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(254,176</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10,695</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(308,962</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(341,881</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Basic and diluted weighted average common shares outstanding</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss per share, basic and diluted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="10" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Accumulated</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Gross</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amortization</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Net Book Value</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Website development costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">70,188</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(70,188</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Media distribution rights</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(25,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Intellectual property</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">LinkedIn Group</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Organization costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,377</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,377</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 36pt;">Total intangibles</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">104,065</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(104,065</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Aggregate</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Contractual</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Intrinsic</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Term (in years)</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Value</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2017</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.60</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">700,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.23</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited or expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at September 30, 2018</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,050,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.47</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.88</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at September 30, 2018</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.60</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&nbsp;</td> <td colspan="4" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0); width: 154%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expected life (in years)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.50</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.00</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.79</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Volatility</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">139.34%</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">162.16</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Dividend yield</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average grant date fair value per option granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 5%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.17</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Second largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Third largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Next three largest clients</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">All other clients</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td> </tr> </table></div> 10849 88111 P3Y 1.3934 1.6216 0.0279 1350000 0.60 700000 400000 300000 0 0.17 1350000 2050000 0.60 0.47 0.1 0.23 P10Y P10Y P5Y P3Y182D P6Y P5Y116D P6Y25D P6Y321D 1707927 2006040 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9:</div> Going Concern</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The accompanying financial statements and notes have been prepared assuming that the Company will continue as a going concern.</div> <div style=" margin: 0pt; text-align: justify;">&nbsp;</div><div style=" margin: 0pt; text-align: justify;"></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">We have had material operating losses and have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet created positive cash flows. These factors raise substantial doubt as to our ability to continue as a going concern. However, we continue to improve our core consulting services revenue and are seeking ways and have implemented plans to reduce operating cost in order to reduce our net operating losses. We believe that our increased revenues and improved net losses in the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>compared to our financial results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>coupled with our cash balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,469,921</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and our belief that sufficient funding <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be available from private placements of equity securities or additional borrowings if needed will enable us to meet our liquidity needs over the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing debt, nor that sufficient capital can be raised through debt or equity financing. The financial statements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.</div></div> 20426158 20426158 20426158 20426158 xbrli:shares xbrli:pure iso4217:USD iso4217:CAD iso4217:USD xbrli:shares 0001535079 2015-01-01 2015-12-31 0001535079 us-gaap:EmployeeStockOptionMember 2016-08-10 2016-08-10 0001535079 2017-01-01 2017-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:AllOtherClientsMember 2017-01-01 2017-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:LargestClientMember 2017-01-01 2017-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:NextThreeLargestClientsMember 2017-01-01 2017-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:SecondLargestClientMember 2017-01-01 2017-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:ThirdLargestClientMember 2017-01-01 2017-09-30 0001535079 us-gaap:ProductAndServiceOtherMember 2017-01-01 2017-09-30 0001535079 us-gaap:ProductMember 2017-01-01 2017-09-30 0001535079 us-gaap:ServiceMember 2017-01-01 2017-09-30 0001535079 2017-01-01 2017-12-31 0001535079 2017-07-01 2017-09-30 0001535079 us-gaap:ProductAndServiceOtherMember 2017-07-01 2017-09-30 0001535079 us-gaap:ProductMember 2017-07-01 2017-09-30 0001535079 us-gaap:ServiceMember 2017-07-01 2017-09-30 0001535079 mccx:A1Point86PercentShareholderMember 2017-10-01 2017-10-31 0001535079 2018-01-01 2018-09-30 0001535079 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0001535079 mccx:EmployeeStockOptionWith10YearTermMember 2018-01-01 2018-09-30 0001535079 mccx:EmployeeStockOptionWith5YearTermMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:AllOtherClientsMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:LargestClientMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:NextThreeLargestClientsMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:SecondLargestClientMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:ThirdLargestClientMember 2018-01-01 2018-09-30 0001535079 us-gaap:ProductAndServiceOtherMember 2018-01-01 2018-09-30 0001535079 us-gaap:ProductMember 2018-01-01 2018-09-30 0001535079 us-gaap:ServiceMember 2018-01-01 2018-09-30 0001535079 srt:MaximumMember 2018-01-01 2018-09-30 0001535079 srt:MinimumMember 2018-01-01 2018-09-30 0001535079 us-gaap:ChiefExecutiveOfficerMember 2018-01-01 2018-09-30 0001535079 mccx:A1Point86PercentShareholderMember 2018-02-01 2018-02-28 0001535079 2018-07-01 2018-09-30 0001535079 us-gaap:ProductAndServiceOtherMember 2018-07-01 2018-09-30 0001535079 us-gaap:ProductMember 2018-07-01 2018-09-30 0001535079 us-gaap:ServiceMember 2018-07-01 2018-09-30 0001535079 mccx:A1Point86PercentShareholderMember 2011-09-16 0001535079 2016-12-31 0001535079 2017-09-30 0001535079 2017-12-31 0001535079 mccx:A1Point86PercentShareholderMember 2017-12-31 0001535079 2018-09-30 0001535079 us-gaap:DevelopedTechnologyRightsMember 2018-09-30 0001535079 us-gaap:DistributionRightsMember 2018-09-30 0001535079 us-gaap:IntellectualPropertyMember 2018-09-30 0001535079 mccx:LinkedInGroupMember 2018-09-30 0001535079 mccx:OrganizationCostsMember 2018-09-30 0001535079 mccx:A1Point86PercentShareholderMember 2018-09-30 0001535079 2019-01-01 2018-09-30 0001535079 2018-09-30 0001535079 2018-11-09 EX-101.SCH 6 mccx-20180930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Disclosure - Note 1 - Organization and Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 2 - Recent Accounting Pronouncements link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 3 - Revenues link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 4 - Capitalized Software Development Costs link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 5 - Intangible Assets link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 6 - Stock-based Compensation link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 7 - Concentrations link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 8 - Debt link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 9 - Going Concern link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 10 - Basic and Diluted Net Income / (Loss) Per Share link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 11 - Related-party Transactions link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 5 - Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 6 - Stock-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 7 - Concentrations (Tables) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 10 - Basic and Diluted Net Income / (Loss) Per Share (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 3 - Revenues 1 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 3 - Revenues 2 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 4 - Capitalized Software Development Costs (Details Textual) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 5 - Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 5 - Intangible Assets - Summary of Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 6 - Stock-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 6 - Stock-based Compensation - Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 6 - Shareholders' Equity - Fair value Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 7 - Concentrations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 7 - Concentrations - Percentage of Sales and the Concentrations (Details) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 8 - Debt (Details Textual) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 9 - Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 10 - Basic and Diluted Net Income / (Loss) Per Share (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 10 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 11 - Related-party Transactions (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 mccx-20180930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 mccx-20180930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 mccx-20180930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Dividend yield Note To Financial Statement Details Textual Note 5 - Intangible Assets Note 6 - Stock-based Compensation Note 7 - Concentrations Risk-free interest rate Note 10 - Basic and Diluted Net Income / (Loss) Per Share Note 5 - Intangible Assets - Summary of Intangible Assets (Details) Note 6 - Stock-based Compensation - Stock Option Activity (Details) Note 6 - Shareholders' Equity - Fair value Assumptions (Details) Note 7 - Concentrations - Percentage of Sales and the Concentrations (Details) Note 10 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) Notes To Financial Statements Notes To Financial Statements [Abstract] Volatility Stock compensation expense Other assets us-gaap_LiabilitiesCurrent Total current liabilities Expected life (in years) (Year) Other current liabilities Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Expenses Share-based Compensation, Activity [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table Text Block] Depreciation and amortization Capitalized software development costs Unamortized costs incurred for development of computer software, which is to be sold, leased or otherwise marketed, after establishing technological feasibility through to the general release of the software products. Excludes capitalized costs of developing software for internal use. Organization Costs [Member] Intangible asset classified as organization costs. LinkedIn Group [Member] Intangible asset classified as the LinkedIn Group. Intangible Assets Disclosure [Text Block] Second Largest Client [Member] Represents the second largest client. Largest Client [Member] Represents the largest client. Next Three Largest Clients [Member] Represents the next three largest clients. Third Largest Client [member] Represents the third largest client. mccx_PercentageOfOwnership Percentage of Ownership Represents the percentage of ownership held by an investor. All Other Clients [Member] Represents the all other clients. us-gaap_AssetsCurrent Total current assets Weighted average exercise price, options exercisable (in dollars per share) Long term assets: Weighted average remaining contractual term, options exercisable (Year) Notes payable Aggregate intrinsic value, options exercisable Options exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted average remaining contractual term, outstanding balance (Year) Aggregate intrinsic value, outstanding balance Weighted average grant date fair value per option granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at September 30, 2018 and December 31, 2017 Adjustments to reconcile net loss to net cash used in operations: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Weighted average exercise price, outstanding balance (in dollars per share) Weighted average exercise price, outstanding balance (in dollars per share) Common stock, shares authorized (in shares) Common stock, shares issued (in shares) Deferred revenue Weighted average exercise price, options forfeited or expired (in dollars per share) Common stock, par value (in dollars per share) Weighted average exercise price, options granted (in dollars per share) Weighted average exercise price, options exercised (in dollars per share) Range [Domain] Maximum [Member] Minimum [Member] Accounts payable Product and Service [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Options outstanding, balance (in shares) Options outstanding, balance (in shares) Product and Service [Domain] Range [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Options forfeited or expired (in shares) Proceeds from sale of equipment us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum Interest paid us-gaap_PolicyTextBlockAbstract Accounting Policies us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax Revenue, net us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Equipment purchases us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Customer [Axis] Customer [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Product and Service, Other [Member] Liabilities: Developed Technology Rights [Member] Product [Member] Supplemental disclosure of cash flow information: us-gaap_Assets Total assets us-gaap_InterestIncomeExpenseNet Interest Income (Expense), Net, Total us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options CASH FLOWS FROM OPERATING ACTIVITIES: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Intellectual Property [Member] Distribution Rights [Member] Statement [Line Items] Accounts receivable Revenue, net Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Additional paid-in capital Shareholders' equity: us-gaap_ContractWithCustomerAssetNet Contract with Customer, Asset, Net, Total Other expense Equity Award [Domain] Current assets: Award Type [Axis] Net loss Net loss us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization Intangible assets, accumulated amortization us-gaap_FiniteLivedIntangibleAssetsNet Intangible assets, net Intangible assets, gross us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash used in financing activities us-gaap_Liabilities Total liabilities Net operating loss us-gaap_ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized Employee Stock Option [Member] us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Decrease in cash and cash equivalents us-gaap_GrossProfit Gross profit us-gaap_CostOfGoodsAndServicesSold Cost of goods sold Property and equipment, net Labor A 1.86% Shareholder [Member] Represents the information pertaining to a 1.86% shareholder. mccx_StatementsOfWorkTerm Statements of Work, Term The period of time for statements of work for each project, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Cost of goods sold INVESTING ACTIVITIES Earnings Per Share [Text Block] us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty Related Party Transaction, Other Revenues from Transactions with Related Party Contract services Related Party Transactions Disclosure [Text Block] Loss before income taxes Income tax provision Equity Components [Axis] Equity Component [Domain] Accounts payable us-gaap_IncreaseDecreaseInAccountsPayable us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period us-gaap_RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] us-gaap_NotesPayable Notes Payable, Total us-gaap_OperatingExpenses Total expenses Other general and administrative Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Other current liabilities us-gaap_IncreaseDecreaseInOtherCurrentLiabilities us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense, Total Revenue from Contract with Customer [Text Block] Amendment Flag Accounting Policies [Abstract] Concentration Risk Disclosure [Text Block] Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Deferred revenue us-gaap_IncreaseDecreaseInContractWithCustomerLiability Common stock, shares outstanding (in shares) Current Fiscal Year End Date us-gaap_DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date us-gaap_DebtInstrumentFeeAmount Debt Instrument, Fee Amount Entity Emerging Growth Company us-gaap_DebtInstrumentFaceAmount Debt Instrument, Face Amount Document Type Entity Small Business Document Information [Line Items] Document Information [Table] Service [Member] Entity Filer Category Entity Current Reporting Status us-gaap_ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived us-gaap_CapitalizedComputerSoftwareAdditions Capitalized Computer Software, Additions Capitalized software development costs, net Capitalized Computer Software, Net, Ending Balance Weighted average common shares outstanding-basic and diluted (in shares) Basic and diluted weighted average common shares outstanding (in shares) Employee Stock Option with 5 Year Term [Member] Information pertaining to employee stock option with a five year term. us-gaap_RepaymentsOfNotesPayable Repayments of Notes Payable Repayment of notes payable us-gaap_CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization Employee Stock Option with 10 Year Term [Member] Information pertaining to employee stock option with a ten year term. us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Concentrations us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable Net loss per share-basic and diluted (in dollars per share) Net loss per share, basic and diluted (in dollars per share) Entity Central Index Key Entity Registrant Name Entity [Domain] Customer Concentration Risk [Member] Legal Entity [Axis] Statement [Table] Scenario [Axis] Statement of Financial Position [Abstract] Scenario, Unspecified [Domain] us-gaap_AmortizationOfIntangibleAssets Amortization of Intangible Assets, Total Concentration Risk Type [Axis] us-gaap_AllowanceForDoubtfulAccountsReceivable Allowance for Doubtful Accounts Receivable, Ending Balance Concentration Risk Type [Domain] Statement of Cash Flows [Abstract] Entity Common Stock, Shares Outstanding (in shares) Income Statement [Abstract] Sales Revenue, Net [Member] us-gaap_IncreaseDecreaseInOtherNoncurrentAssets Other assets Trading Symbol Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] mccx_CapitalizedComputerSoftwareUsefulLife Capitalized Computer Software, Useful Life The useful life of capitalized computer software. us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Options exercised (in shares) us-gaap_TableTextBlock Notes Tables us-gaap_GainLossOnDispositionOfAssets1 Loss on disposal of assets New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Chief Executive Officer [Member] Related Party [Axis] Related Party [Domain] Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross FINANCING ACTIVITIES us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and shareholders' equity Accumulated deficit Research, Development, and Computer Software Disclosure [Text Block] Debt Disclosure [Text Block] us-gaap_InterestExpense Interest expense Changes in operating assets and liabilities: us-gaap_StockholdersEquity Total shareholders' equity us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] us-gaap_ForeignCurrencyTransactionGainLossRealized Unrealized loss (gain) on foreign currency transactions Class of Stock [Axis] us-gaap_ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Intangible assets, net Salaries and wages EX-101.PRE 10 mccx-20180930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 09, 2018
Document Information [Line Items]    
Entity Registrant Name McorpCX, Inc.  
Entity Central Index Key 0001535079  
Trading Symbol mccx  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Current Reporting Status Yes  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Common Stock, Shares Outstanding (in shares)   20,426,158
Document Type 10-Q  
Document Period End Date Sep. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 1,469,921 $ 1,616,076
Accounts receivable 481,919 274,785
Total current assets 1,951,840 1,890,861
Long term assets:    
Property and equipment, net 89,576 86,551
Capitalized software development costs, net 156,199 301,574
Intangible assets, net 6,250
Other assets 62,496 27,137
Total assets 2,260,111 2,312,373
Liabilities:    
Accounts payable 481,691 218,107
Deferred revenue 68,343 80,057
Other current liabilities 2,150
Notes payable 8,169
Total current liabilities 552,184 306,333
Total liabilities 552,184 306,333
Shareholders' equity:    
Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at September 30, 2018 and December 31, 2017
Additional paid-in capital 6,439,846 6,428,997
Accumulated deficit (4,731,919) (4,422,957)
Total shareholders' equity 1,707,927 2,006,040
Total liabilities and shareholders' equity $ 2,260,111 $ 2,312,373
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
$ / shares in Thousands
Sep. 30, 2018
Dec. 31, 2017
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 20,426,158 20,426,158
Common stock, shares outstanding (in shares) 20,426,158 20,426,158
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue, net        
Revenue, net $ 933,836 $ 647,436 $ 2,952,344 $ 1,547,340
Cost of goods sold        
Cost of goods sold 622,428 266,085 1,660,632 646,059
Gross profit 311,408 381,351 1,291,712 901,281
Expenses        
Salaries and wages 251,111 214,923 684,029 713,363
Contract services 47,202 4,758 161,453 35,468
Other general and administrative 262,851 166,139 749,612 485,357
Total expenses 561,164 385,820 1,595,094 1,234,188
Net operating loss (249,756) (4,469) (303,382) (332,907)
Interest expense (645) (2,449) (1,048) (8,191)
Other expense (3,775) (3,777) (4,532) (783)
Loss before income taxes (254,176) (10,695) (308,962) (341,881)
Income tax provision
Net loss $ (254,176) $ (10,695) $ (308,962) $ (341,881)
Net loss per share-basic and diluted (in dollars per share) $ (0.01) $ 0 $ (0.02) $ (0.02)
Weighted average common shares outstanding-basic and diluted (in shares) 20,426,158 20,426,158 20,426,158 20,426,158
Service [Member]        
Revenue, net        
Revenue, net $ 772,081 $ 539,562 $ 2,567,153 $ 1,304,541
Product and Service, Other [Member]        
Revenue, net        
Revenue, net 161,755 107,874 385,191 242,799
Cost of goods sold        
Cost of goods sold 215,007 120,055 540,130 320,577
Product [Member]        
Cost of goods sold        
Labor $ 407,421 $ 146,030 $ 1,120,502 $ 325,482
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (308,962) $ (341,881)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation and amortization 153,074 169,658
Stock compensation expense 10,849 88,111
Loss on disposal of assets 298
Unrealized loss (gain) on foreign currency transactions (2,149)
Changes in operating assets and liabilities:    
Accounts receivable (207,134) (147,878)
Other assets (35,359) (2,854)
Accounts payable 263,584 98,853
Other current liabilities 2,150 2,183
Deferred revenue (11,714) (12,282)
Net cash used in operating activities (133,512) (147,941)
INVESTING ACTIVITIES    
Equipment purchases (4,474) (2,353)
Proceeds from sale of equipment 2,000
Capitalized software development costs (93,803)
Net cash used in investing activities (4,474) (94,156)
FINANCING ACTIVITIES    
Repayment of notes payable (8,169)
Net cash used in financing activities (8,169)
Decrease in cash and cash equivalents (146,155) (242,097)
Cash and cash equivalents, beginning of period 1,616,076 1,925,744
Cash and cash equivalents, end of period 1,469,921 1,683,647
Supplemental disclosure of cash flow information:    
Interest paid $ 1,048 $ 5,966
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 1 - Organization and Basis of Presentation
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note
1:
Organization and Basis of Presentation
 
McorpCX, Inc. (“we,” “us,” “our,” or the “Company”) was incorporated in the State of California on
December 14, 2001.
We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue.
 
We are a customer experience services company, delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand “cloud based” customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization.
 
The financial statements and related disclosures as of and for the
three
and
nine
months ended
September 30, 2018
and
2017,
are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The balance sheet as of
December 31, 2017
was derived from the audited financial statements included in our Annual Report on Form
10
-K for the year ended
December 31, 2017.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These financial statements should be read in conjunction with the financial statements included in our Annual Report for the year ended
December 31, 2017,
filed on Form
10
-K with the SEC on
March 29, 2018. 
The results of operations for the
three
and
nine
months ended
September 30, 2018,
are
not
necessarily indicative of the results to be expected for the full year. Unless the context otherwise requires, all references to "McorpCX," "we," "us," "our" or the "Company" are to McorpCX, Inc.
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Recent Accounting Pronouncements
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Note
2:
Recent Accounting Pronouncements
 
In
January 2017,
the FASB issued ASU
No.
2017
-
03,
Accounting Changes and Error Corrections (Topic
250
) and Investments—Equity Method and Joint Ventures (Topic
323
). The ASU adds SEC disclosure requirements for both the quantitative and qualitative impacts that certain recently issued accounting standards will have on the financial statements of a registrant when such standards are adopted in a future period. Specially, these disclosure requirements apply to the adoption of ASU
No.
2014
-
09,;
ASU
No.
2016
-
02,
Leases (Topic
842
); and ASU
No.
2016
-
13,
Financial Instruments—Credit Losses (Topic
326
): Measurement of Credit Losses on Financial Instruments. In addition, ASU
No.
2017
-
03
conforms certain paragraphs within the SEC Staff Guidance to the guidance issued in Accounting Standards Update
No.
2014
-
01,
Investments—Equity Method and Joint Ventures (Topic
323
): Accounting for Investments in Qualified Affordable Housing Projects. The Company is currently evaluating the impact of these amendments on its financial statements.
 
In
May 2017,
the FASB issued ASU
No.
2017
-
09,
Compensation—Stock Compensation (Topic
718
): Scope of Modification Accounting, to provide clarity and reduce both (
1
) diversity in practice and (
2
) cost and complexity when applying the guidance in Topic
718,
Compensation—Stock Compensation, to a change to the terms or conditions of a share-based payment award. The ASU provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in ASC
718.
The amendments are effective for fiscal years beginning after
December 15, 2017
and should be applied prospectively to an award modified on or after the adoption date. Early adoption is permitted, including adoption in an interim period. The Company adopted ASU
2017
-
09
with
no
material impact to the financial statements.
 
In
May 2014,
the FASB issued Accounting Standards Update
No.
2014
-
09
(Topic
606
) "Revenue from Contracts with Customers." Topic
606
supersedes the revenue recognition requirements in Topic
605
“Revenue Recognition” (Topic
605
) and requires entities to recognize revenue when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We adopted Topic
606
as of
January 1, 2018
using the modified retrospective transition method. See Note
3
 for further details.
 
In
November 2017,
the FASB issued ASU
No.
2017
-
14,
Income Statement—Reporting Comprehensive Income (Topic
220
), Revenue Recognition (Topic
605
), and Revenue from Contracts with Customers (Topic
606
) (SEC Update). The ASU amends SEC paragraphs pursuant to the SEC Staff Accounting Bulletin
No.
116
and SEC Release
No.
33
-
10403,
which bring existing guidance into conformity with Topic
606,
Revenue from Contracts with Customers. The amendments were effective upon issuance. The Company has evaluated the impact on revenue recognition and does
not
expect these amendments to have a material effect on its financial statements.
 
In
February 2018,
the FASB issued ASU
No.
2018
-
03,
Technical Corrections and Improvements to Financial Instruments — Overall (Subtopic
825
-
10
): Recognition and Measurement of Financial Assets and Financial Liabilities, which retained the current framework for accounting for financial instruments in generally accepted accounting principles (GAAP) but made targeted improvements to address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The amendments in this Update are effective for fiscal years beginning after
December 15, 2017,
and interim periods within those fiscal years beginning after
June 15, 2018.
The Company adopted ASU
2018
-
03
with
no
material impact to the financial statements.
 
In
February 2018,
the FASB issued ASU
No.
2018
-
02,
Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC
220,
Income Statement — Reporting Comprehensive Income, to “allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.” In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after
December 15, 2018,
and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU
No.
2018
-
02
on its consolidated financial statements.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Revenues
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]
Note
3.
 Revenues
 
Adoption of ASC Topic
606,
"Revenue from Contracts with Customers"
 
On 
January 
1,
2018
we adopted Topic
606
using the modified retrospective method applied to those contracts which were
not
completed as of 
January 
1,
2018.
Results for reporting periods beginning after 
January 
1,
2018
 are presented under Topic
606,
while prior period amounts are
not
adjusted and continue to be reported in accordance with our historic accounting under Topic
605.
 
We did
not
have a cumulative impact as of 
January 
1,
2018
 due to the adoption of Topic
606
and there was
not
an impact to our statements of operations for the
three
and
nine
months ended 
September 30, 2018 
as a result of applying Topic
606.
 
Revenue Recognition
 
The Company’s revenue consists primarily of professional and consulting services, as well as reimbursable expenses billed to clients, software-enabled product sales and other revenues. Consulting services include customer experience management consulting in the areas of strategy development, planning, education, training and program design, and includes the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. Product revenue is from productized and software-enabled service sales
not
elsewhere classified, while other revenue includes reimbursement of related travel costs and out-of-pocket expenses.
 
The consulting services are contracted under master terms and conditions with statements of work (“SOW”) defined for each project. A typical consulting SOW will span a period of
60
-
180
days and will usually be billed to the client based on certain milestones being achieved throughout the SOW. The Company recognizes revenue based upon a percentage of completion of each SOW during each project, which are typically
60
-
180
days in duration. In addition, we typically incur travel other miscellaneous expenses during work on each SOW which we bill to our clients for reimbursement. The travel and miscellaneous expenses are recognized in revenue on a percentage of work complete basis.
 
Contract costs, such as commissions, are typically incurred contemporaneously with the pattern of revenue recognition and, as such, are expensed as incurred.
 
Consulting Service Revenues
 
The Company’s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the customer experience being analyzed. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has
no
alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract.
 
Product and other revenue
  
Product and other revenue during
2018
has primarily been derived from reimbursable expenses charged to clients and to a lesser degree from product sales and related revenue.  The product related portion of this revenue originates from the utilization of the Company’s web-hosted Touchpoint Mapping On-Demand application (“Touchpoint Mapping”), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services.  Customer licenses for Touchpoint Mapping are
not
subject to the licensing guidance in Topic
606
because the customer can’t take possession of the software at any time and the customer would
not
be able to operate the software on its own or with another
third
party. Fees charged to customers of Touchpoint Mapping
may
include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company’s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does
not
affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do
not
unbundle such services into separate performance obligations as their pattern of transfer does
not
differ.
 
The aggregate amount of the fees received from customers that are allocated to product and other revenue performance obligations that are unsatisfied (or partially unsatisfied) as of
September 30, 2018
is
$68,343
and included in deferred revenue on the accompanying balance sheet. The Company expects to recognize revenue of
$68,343
in the next
12
months related to these unsatisfied (or partially unsatisfied) performance obligations. Revenue related to these performance obligations are
not
expected to be recognized beyond fiscal year
2018.
 
 
Arrangements with Multiple Performance Obligations
 
The Company’s contracts with customers
may
include multiple performance obligations. For such arrangements, the Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the prices charged to customers. If the pattern of transfer of control for each obligation does
not
differ, the Company does
not
allocate revenue to specific performance obligations.
 
Deferred Revenues (Contract Liabilities)
 
The Company records deferred revenues when cash payments are received or due in advance of our performance, including amounts which are refundable.
 
Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is
not
significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer.
 
During the
nine
months ended
September 30, 2018,
we recognized revenue of
$80,057,
related to our contract liabilities included in deferred revenue at
December 31, 2017.
During the
nine
months ended
September 30, 2017
we recognized revenue of
$51,029,
related to our contract liabilities included in deferred revenue at
December 31, 2016.
There was
no
revenue recognized for the
three
months ended
September 30, 2018
or
2017
related to deferred revenue balances for
December 31, 2017
and
2016,
respectively.
 
 
Contract Assets
 
Given the nature of the Company’s services and contracts, it has
no
contract assets.
 
Practical Expedients and Exemptions
 
Contract costs consist primarily of sales commissions, The Company generally expenses sales commissions when incurred because the amortization period would have been
one
year or less and they are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses.
 
The Company does
not
disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of
one
year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
 
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 4 - Capitalized Software Development Costs
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Research, Development, and Computer Software Disclosure [Text Block]
Note
4:
Capitalized Software Development Costs
 
 
Costs incurred to develop Software as a Service (SaaS) technology consist of external direct costs of materials and services and payroll and payroll-related costs for employees who directly devote time to the project. Research and development costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when technological feasibility is established. Costs incurred during the operating stage of the software application relating to upgrades and enhancements are capitalized to the extent that they result in the extended life of the product. All other costs are expensed as incurred. Expenses relating to upgrades and enhancements were capitalized during the
nine
months ended
September 30, 2017
in the amount of
$93,803.
There were
no
expenses capitalized during the
nine
months ended
September 30, 2018.
 
Amortization of software development costs commenced when the product was available for general release to customers. The capitalized costs are amortized on a straight-line basis over the
three
-year expected useful life of the software. Capitalized software development costs, net of amortization, were
$156,199
and
$301,574
as of
September 30, 2018
and
December 31, 2017,
respectively. Amortization expense incurred during the
nine
months ended
September 30, 2018
and
2017
was
$145,375
and
$142,277,
respectively and is included in cost of goods sold in the statements of operations.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Intangible Assets
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]
Note
5:
Intangible Assets
 
Intangibles consist of the following as of
September 30, 2018.
 
   
2018
 
   
 
 
 
 
Accumulated
   
 
 
 
   
Gross
   
Amortization
   
Net Book Value
 
Website development costs
  $
70,188
    $
(70,188
)   $
-
 
Media distribution rights
   
25,000
     
(25,000
)    
-
 
Intellectual property
   
5,000
     
(5,000
)    
-
 
LinkedIn Group
   
2,500
     
(2,500
)    
-
 
Organization costs
   
1,377
     
(1,377
)    
-
 
Total intangibles
  $
104,065
    $
(104,065
)   $
-
 
 
Total amortization of intangible assets was
$6,250
and
$22,906
for the
nine
months ended
September 30, 2018
and
2017,
respectively.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 6 - Stock-based Compensation
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note
6:
Stock-Based Compensation
 
In
December 2015,
we adopted a revised share option plan in which Plan Shares cannot exceed
10%
of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a
10
-year term. This share option plan was approved by the Company’s shareholders at the annual meeting of shareholders on
August 10, 2016.
 
To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price.  The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin
No.
110.
  The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.
 
At
September 30, 2018,
1,350,000
stock options were exercisable and
$10,849
of total compensation cost related to share-based compensation grants had been recognized for the
nine
months ended
September 30, 2018.
Unrecognized compensation expense from stock options was
$116,226
at
September 30, 2018,
which is expected to be recognized over a weighted-average vesting period of
2.88
years beginning
October 1, 2018.
 
The following table summarizes our stock option activity for the
nine
months ended
September 30, 2018:
 
   
 
 
 
 
 
 
 
 
Weighted
   
 
 
 
   
 
 
 
 
Weighted
   
Average
   
 
 
 
   
 
 
 
 
Average
   
Remaining
   
Aggregate
 
   
Number of
   
Exercise
   
Contractual
   
Intrinsic
 
   
Shares
   
Price
   
Term (in years)
   
Value
 
Outstanding at December 31, 2017
   
1,350,000
    $
0.60
     
6.07
     
-
 
Granted
   
700,000
     
0.23
     
6.00
     
-
 
Exercised
   
-
     
-
     
-
     
-
 
Forfeited or expired
   
-
     
-
     
-
     
-
 
Outstanding at September 30, 2018
   
2,050,000
    $
0.47
     
6.88
     
-
 
Exercisable at September 30, 2018
   
1,350,000
    $
0.60
     
5.32
    $
-
 
 
During the
nine
months ended
September 30, 2018,
the Company granted
700,000
options to certain employees of the Company with an incremental vesting schedule over
3
years and a weighted-average grant date fair value of
$0.17
.
Of the total options granted during the period
400,000
have a
ten
year term and
300,000
have a
five
year term. The following assumptions were used to calculate weighted average fair values of the options granted in the
nine
months ended
September 30, 2018.
There were
no
options granted during the
nine
months ended
September 30, 2017. 
 
   
2018
 
Expected life (in years)
   
3.50
-
6.00
 
Risk-free interest rate
   
 
 
2.79
%
Volatility
   
139.34%
-
162.16
%
Dividend yield
   
 
 
-
 
Weighted average grant date fair value per option granted
  $
 
 
0.17
 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Concentrations
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Concentration Risk Disclosure [Text Block]
Note
7:
Concentrations
 
We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune
500
companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the
nine
months ended
September 30, 2018
and
2017,
the percentage of sales and the concentrations are:
 
   
2018
   
2017
 
Largest client
   
39
%    
31
%
Second largest client
   
28
%    
17
%
Third largest client
   
13
%    
16
%
Next three largest clients
   
15
%    
23
%
All other clients
   
5
%    
13
%
     
100
%    
100
%
 
Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is
no
provision made to include an allowance for doubtful accounts.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 8 - Debt
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Debt Disclosure [Text Block]
Note
8:
Debt
 
On
September 16, 2011,
a
$100,000
CAD note was executed with an individual, a
1.86%
shareholder. The note is structured to incur a balloon payment of the principal and
4%
APR
non-compounding accrued interest on its amended maturity date of
October 31, 2017.
Effective
October 31, 2016
the note's previous maturity date of
September 16, 2016
was amended to extend the maturity date to
October 31, 2017.
In
October 2017,
$66,217
was paid to the note holder and the remaining balance of
$8,169
was paid in
February 2018
fully satisfying the debt. The balance of
$8,169
is presented under notes payable on the balance sheet as of
December 31, 2017
and there were 
no
fees or penalties incurred by the Company. There was
no
notes payable balance as of
September 30, 2018.
We have recorded a foreign currency loss of
$911
and gain of
$1,409
during the
nine
months ended
September 30, 2018
and
2017,
respectively, related to the revaluation of this note's principal from CAD to USD.
 
Interest expense was
$1,048
and
$8,191
for the
nine
months ended
September 30, 2018
and
2017,
respectively and consists of interest on our short-term promissory notes, and credit card balances.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 9 - Going Concern
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]
Note
9:
Going Concern
 
The accompanying financial statements and notes have been prepared assuming that the Company will continue as a going concern.
 
We have had material operating losses and have
not
yet created positive cash flows. These factors raise substantial doubt as to our ability to continue as a going concern. However, we continue to improve our core consulting services revenue and are seeking ways and have implemented plans to reduce operating cost in order to reduce our net operating losses. We believe that our increased revenues and improved net losses in the year ended
December 31, 2017
and the
nine
months ended
September 30, 2018
compared to our financial results for the
nine
months ended
September 30, 2017
coupled with our cash balance of
$1,469,921
at
September 30, 2018
and our belief that sufficient funding
may
be available from private placements of equity securities or additional borrowings if needed will enable us to meet our liquidity needs over the next
12
months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing debt, nor that sufficient capital can be raised through debt or equity financing. The financial statements do
not
include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Basic and Diluted Net Income / (Loss) Per Share
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Earnings Per Share [Text Block]
Note
10:
Basic and Diluted Net Income / (Loss) per Share
 
The Company follows FASB ASC
260,
“Earnings Per Share”, when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per share. Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. For the
three
and
nine
months ended
September 30, 2018
and
2017,
the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net income (loss) per share basic and diluted are equal in all periods presented. Securities that were
not
included in the diluted per share calculations because they would be anti-dilutive were vested options to purchase common stock of
1,350,000
and
1,425,000
as of
September 30, 2018
and
2017,
respectively.
 
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2018
   
2017
   
2018
   
2017
 
Net loss
  $
(254,176
)
  $
(10,695
)
  $
(308,962
)
  $
(341,881
)
Basic and diluted weighted average common shares outstanding
   
20,426,158
     
20,426,158
     
20,426,158
     
20,426,158
 
                                 
Net loss per share, basic and diluted
  $
(0.01
)
  $
(0.00
)
  $
(0.02
)
  $
(0.02
)
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 11 - Related-party Transactions
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
Note
11:
Related-Party Transactions
 
During the
nine
months ended
September 30, 2018,
a company controlled by the Company’s former Chief Executive Officer purchased from the Company an internet domain name that was obsolete and
not
being used in the business nor needed for the go-forward business for
$2,000
that is included in other income (expense) on the statements of operations.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Intangible Assets (Tables)
9 Months Ended
Sep. 30, 2018
Notes Tables  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
   
2018
 
   
 
 
 
 
Accumulated
   
 
 
 
   
Gross
   
Amortization
   
Net Book Value
 
Website development costs
  $
70,188
    $
(70,188
)   $
-
 
Media distribution rights
   
25,000
     
(25,000
)    
-
 
Intellectual property
   
5,000
     
(5,000
)    
-
 
LinkedIn Group
   
2,500
     
(2,500
)    
-
 
Organization costs
   
1,377
     
(1,377
)    
-
 
Total intangibles
  $
104,065
    $
(104,065
)   $
-
 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 6 - Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2018
Notes Tables  
Share-based Compensation, Activity [Table Text Block]
   
 
 
 
 
 
 
 
 
Weighted
   
 
 
 
   
 
 
 
 
Weighted
   
Average
   
 
 
 
   
 
 
 
 
Average
   
Remaining
   
Aggregate
 
   
Number of
   
Exercise
   
Contractual
   
Intrinsic
 
   
Shares
   
Price
   
Term (in years)
   
Value
 
Outstanding at December 31, 2017
   
1,350,000
    $
0.60
     
6.07
     
-
 
Granted
   
700,000
     
0.23
     
6.00
     
-
 
Exercised
   
-
     
-
     
-
     
-
 
Forfeited or expired
   
-
     
-
     
-
     
-
 
Outstanding at September 30, 2018
   
2,050,000
    $
0.47
     
6.88
     
-
 
Exercisable at September 30, 2018
   
1,350,000
    $
0.60
     
5.32
    $
-
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
2018
 
Expected life (in years)
   
3.50
-
6.00
 
Risk-free interest rate
   
 
 
2.79
%
Volatility
   
139.34%
-
162.16
%
Dividend yield
   
 
 
-
 
Weighted average grant date fair value per option granted
  $
 
 
0.17
 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Concentrations (Tables)
9 Months Ended
Sep. 30, 2018
Notes Tables  
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
   
2018
   
2017
 
Largest client
   
39
%    
31
%
Second largest client
   
28
%    
17
%
Third largest client
   
13
%    
16
%
Next three largest clients
   
15
%    
23
%
All other clients
   
5
%    
13
%
     
100
%    
100
%
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Basic and Diluted Net Income / (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2018
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2018
   
2017
   
2018
   
2017
 
Net loss
  $
(254,176
)
  $
(10,695
)
  $
(308,962
)
  $
(341,881
)
Basic and diluted weighted average common shares outstanding
   
20,426,158
     
20,426,158
     
20,426,158
     
20,426,158
 
                                 
Net loss per share, basic and diluted
  $
(0.01
)
  $
(0.00
)
  $
(0.02
)
  $
(0.02
)
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Revenues 1 (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue, Remaining Performance Obligation, Amount $ 68,343   $ 68,343  
Contract with Customer, Liability, Revenue Recognized 0 $ 0 80,057 $ 51,029
Contract with Customer, Asset, Net, Total $ 0   $ 0  
Minimum [Member]        
Statements of Work, Term     60 days  
Maximum [Member]        
Statements of Work, Term     180 days  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Revenues 2 (Details Textual)
Sep. 30, 2018
USD ($)
Revenue, Remaining Performance Obligation, Amount $ 68,343
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01  
Revenue, Remaining Performance Obligation, Amount $ 68,343
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: (nil)  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 1 year
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 4 - Capitalized Software Development Costs (Details Textual) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Capitalized Computer Software, Additions $ 0 $ 93,803  
Capitalized Computer Software, Useful Life 3 years    
Capitalized Computer Software, Net, Ending Balance $ 156,199   $ 301,574
Capitalized Computer Software, Amortization $ 145,375 $ 142,277  
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Intangible Assets (Details Textual) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Amortization of Intangible Assets, Total $ 6,250 $ 22,906
Impairment of Intangible Assets, Finite-lived   $ 0
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Intangible Assets - Summary of Intangible Assets (Details)
Sep. 30, 2018
USD ($)
Intangible assets, gross $ 104,065
Intangible assets, accumulated amortization (104,065)
Intangible assets, net
Developed Technology Rights [Member]  
Intangible assets, gross 70,188
Intangible assets, accumulated amortization (70,188)
Intangible assets, net
Distribution Rights [Member]  
Intangible assets, gross 25,000
Intangible assets, accumulated amortization (25,000)
Intangible assets, net
Intellectual Property [Member]  
Intangible assets, gross 5,000
Intangible assets, accumulated amortization (5,000)
Intangible assets, net
LinkedIn Group [Member]  
Intangible assets, gross 2,500
Intangible assets, accumulated amortization (2,500)
Intangible assets, net
Organization Costs [Member]  
Intangible assets, gross 1,377
Intangible assets, accumulated amortization (1,377)
Intangible assets, net
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 6 - Stock-based Compensation (Details Textual) - USD ($)
9 Months Ended 12 Months Ended
Aug. 10, 2016
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum       10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number   1,350,000    
Allocated Share-based Compensation Expense, Total   $ 10,849    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options   $ 116,226    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   700,000 0  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 0.17    
Employee Stock Option [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years      
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition   2 years 321 days    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   3 years    
Employee Stock Option with 10 Year Term [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period   10 years    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   400,000    
Employee Stock Option with 5 Year Term [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period   5 years    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   300,000    
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 6 - Stock-based Compensation - Stock Option Activity (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Options outstanding, balance (in shares) 1,350,000    
Weighted average exercise price, outstanding balance (in dollars per share) $ 0.60    
Weighted average remaining contractual term, outstanding balance (Year) 6 years 321 days   6 years 25 days
Aggregate intrinsic value, outstanding balance  
Options granted (in shares) 700,000 0  
Weighted average exercise price, options granted (in dollars per share) $ 0.23    
Options exercised (in shares)    
Weighted average exercise price, options exercised (in dollars per share)    
Options forfeited or expired (in shares)    
Weighted average exercise price, options forfeited or expired (in dollars per share)    
Options outstanding, balance (in shares) 2,050,000   1,350,000
Weighted average exercise price, outstanding balance (in dollars per share) $ 0.47   $ 0.60
Options exercisable (in shares) 1,350,000    
Weighted average exercise price, options exercisable (in dollars per share) $ 0.60    
Weighted average remaining contractual term, options exercisable (Year) 5 years 116 days    
Aggregate intrinsic value, options exercisable    
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 6 - Shareholders' Equity - Fair value Assumptions (Details)
9 Months Ended
Sep. 30, 2018
$ / shares
Risk-free interest rate 2.79%
Dividend yield
Weighted average grant date fair value per option granted (in dollars per share) $ 0.17
Minimum [Member]  
Expected life (in years) (Year) 3 years 182 days
Volatility 139.34%
Maximum [Member]  
Expected life (in years) (Year) 6 years
Volatility 162.16%
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Concentrations (Details Textual)
$ in Thousands
Sep. 30, 2018
USD ($)
Allowance for Doubtful Accounts Receivable, Ending Balance $ 0
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Concentrations - Percentage of Sales and the Concentrations (Details) - Customer Concentration Risk [Member] - Sales Revenue, Net [Member]
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Concentrations 100.00% 100.00%
Largest Client [Member]    
Concentrations 39.00% 31.00%
Second Largest Client [Member]    
Concentrations 28.00% 17.00%
Third Largest Client [member]    
Concentrations 13.00% 16.00%
Next Three Largest Clients [Member]    
Concentrations 15.00% 23.00%
All Other Clients [Member]    
Concentrations 5.00% 13.00%
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 8 - Debt (Details Textual)
1 Months Ended 9 Months Ended
Feb. 28, 2018
USD ($)
Oct. 31, 2017
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Dec. 31, 2017
USD ($)
Sep. 16, 2011
CAD ($)
Repayments of Notes Payable     $ 8,169    
Foreign Currency Transaction Loss, before Tax     911 1,409    
Interest Income (Expense), Net, Total     (1,048) $ (8,191)    
A 1.86% Shareholder [Member]            
Debt Instrument, Face Amount           $ 100,000
Percentage of Ownership           1.86%
Debt Instrument, Interest Rate, Effective Percentage           4.00%
Repayments of Notes Payable $ 8,169 $ 66,217        
Debt Instrument, Fee Amount         $ 0  
Notes Payable, Total     $ 0      
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 9 - Going Concern (Details Textual) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Sep. 30, 2017
Dec. 31, 2016
Cash and Cash Equivalents, at Carrying Value, Ending Balance $ 1,469,921 $ 1,616,076 $ 1,683,647 $ 1,925,744
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Basic and Diluted Net Income / (Loss) Per Share (Details Textual) - shares
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 1,350,000 1,425,000
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Net loss $ (254,176) $ (10,695) $ (308,962) $ (341,881)
Basic and diluted weighted average common shares outstanding (in shares) 20,426,158 20,426,158 20,426,158 20,426,158
Net loss per share, basic and diluted (in dollars per share) $ (0.01) $ 0 $ (0.02) $ (0.02)
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 11 - Related-party Transactions (Details Textual)
9 Months Ended
Sep. 30, 2018
USD ($)
Chief Executive Officer [Member]  
Related Party Transaction, Other Revenues from Transactions with Related Party $ 2,000
EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 47 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 54 136 1 false 23 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.mcorpcx.com/20180930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Balance Sheets (Current Period Unaudited) Sheet http://www.mcorpcx.com/20180930/role/statement-balance-sheets-current-period-unaudited Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.mcorpcx.com/20180930/role/statement-balance-sheets-current-period-unaudited-parentheticals Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Statements of Operations (Unaudited) Sheet http://www.mcorpcx.com/20180930/role/statement-statements-of-operations-unaudited Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.mcorpcx.com/20180930/role/statement-statements-of-cash-flows-unaudited Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - Note 1 - Organization and Basis of Presentation Sheet http://www.mcorpcx.com/20180930/role/statement-note-1-organization-and-basis-of-presentation Note 1 - Organization and Basis of Presentation Notes 6 false false R7.htm 006 - Disclosure - Note 2 - Recent Accounting Pronouncements Sheet http://www.mcorpcx.com/20180930/role/statement-note-2-recent-accounting-pronouncements Note 2 - Recent Accounting Pronouncements Notes 7 false false R8.htm 007 - Disclosure - Note 3 - Revenues Sheet http://www.mcorpcx.com/20180930/role/statement-note-3-revenues Note 3 - Revenues Notes 8 false false R9.htm 008 - Disclosure - Note 4 - Capitalized Software Development Costs Sheet http://www.mcorpcx.com/20180930/role/statement-note-4-capitalized-software-development-costs- Note 4 - Capitalized Software Development Costs Notes 9 false false R10.htm 009 - Disclosure - Note 5 - Intangible Assets Sheet http://www.mcorpcx.com/20180930/role/statement-note-5-intangible-assets Note 5 - Intangible Assets Notes 10 false false R11.htm 010 - Disclosure - Note 6 - Stock-based Compensation Sheet http://www.mcorpcx.com/20180930/role/statement-note-6-stockbased-compensation Note 6 - Stock-based Compensation Notes 11 false false R12.htm 011 - Disclosure - Note 7 - Concentrations Sheet http://www.mcorpcx.com/20180930/role/statement-note-7-concentrations- Note 7 - Concentrations Notes 12 false false R13.htm 012 - Disclosure - Note 8 - Debt Sheet http://www.mcorpcx.com/20180930/role/statement-note-8-debt Note 8 - Debt Notes 13 false false R14.htm 013 - Disclosure - Note 9 - Going Concern Sheet http://www.mcorpcx.com/20180930/role/statement-note-9-going-concern Note 9 - Going Concern Notes 14 false false R15.htm 014 - Disclosure - Note 10 - Basic and Diluted Net Income / (Loss) Per Share Sheet http://www.mcorpcx.com/20180930/role/statement-note-10-basic-and-diluted-net-income-loss-per-share Note 10 - Basic and Diluted Net Income / (Loss) Per Share Notes 15 false false R16.htm 015 - Disclosure - Note 11 - Related-party Transactions Sheet http://www.mcorpcx.com/20180930/role/statement-note-11-relatedparty-transactions Note 11 - Related-party Transactions Notes 16 false false R17.htm 016 - Disclosure - Note 5 - Intangible Assets (Tables) Sheet http://www.mcorpcx.com/20180930/role/statement-note-5-intangible-assets-tables Note 5 - Intangible Assets (Tables) Tables http://www.mcorpcx.com/20180930/role/statement-note-5-intangible-assets 17 false false R18.htm 017 - Disclosure - Note 6 - Stock-based Compensation (Tables) Sheet http://www.mcorpcx.com/20180930/role/statement-note-6-stockbased-compensation-tables Note 6 - Stock-based Compensation (Tables) Tables http://www.mcorpcx.com/20180930/role/statement-note-6-stockbased-compensation 18 false false R19.htm 018 - Disclosure - Note 7 - Concentrations (Tables) Sheet http://www.mcorpcx.com/20180930/role/statement-note-7-concentrations-tables Note 7 - Concentrations (Tables) Tables http://www.mcorpcx.com/20180930/role/statement-note-7-concentrations- 19 false false R20.htm 019 - Disclosure - Note 10 - Basic and Diluted Net Income / (Loss) Per Share (Tables) Sheet http://www.mcorpcx.com/20180930/role/statement-note-10-basic-and-diluted-net-income-loss-per-share-tables Note 10 - Basic and Diluted Net Income / (Loss) Per Share (Tables) Tables http://www.mcorpcx.com/20180930/role/statement-note-10-basic-and-diluted-net-income-loss-per-share 20 false false R21.htm 020 - Disclosure - Note 3 - Revenues 1 (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-3-revenues-1-details-textual Note 3 - Revenues 1 (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-3-revenues 21 false false R22.htm 021 - Disclosure - Note 3 - Revenues 2 (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-3-revenues-2-details-textual Note 3 - Revenues 2 (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-3-revenues 22 false false R23.htm 022 - Disclosure - Note 4 - Capitalized Software Development Costs (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-4-capitalized-software-development-costs-details-textual Note 4 - Capitalized Software Development Costs (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-4-capitalized-software-development-costs- 23 false false R24.htm 023 - Disclosure - Note 5 - Intangible Assets (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-5-intangible-assets-details-textual Note 5 - Intangible Assets (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-5-intangible-assets-tables 24 false false R25.htm 024 - Disclosure - Note 5 - Intangible Assets - Summary of Intangible Assets (Details) Sheet http://www.mcorpcx.com/20180930/role/statement-note-5-intangible-assets-summary-of-intangible-assets-details Note 5 - Intangible Assets - Summary of Intangible Assets (Details) Details 25 false false R26.htm 025 - Disclosure - Note 6 - Stock-based Compensation (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-6-stockbased-compensation-details-textual Note 6 - Stock-based Compensation (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-6-stockbased-compensation-tables 26 false false R27.htm 026 - Disclosure - Note 6 - Stock-based Compensation - Stock Option Activity (Details) Sheet http://www.mcorpcx.com/20180930/role/statement-note-6-stockbased-compensation-stock-option-activity-details Note 6 - Stock-based Compensation - Stock Option Activity (Details) Details 27 false false R28.htm 027 - Disclosure - Note 6 - Shareholders' Equity - Fair value Assumptions (Details) Sheet http://www.mcorpcx.com/20180930/role/statement-note-6-shareholders-equity-fair-value-assumptions-details Note 6 - Shareholders' Equity - Fair value Assumptions (Details) Details 28 false false R29.htm 028 - Disclosure - Note 7 - Concentrations (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-7-concentrations-details-textual Note 7 - Concentrations (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-7-concentrations-tables 29 false false R30.htm 029 - Disclosure - Note 7 - Concentrations - Percentage of Sales and the Concentrations (Details) Sheet http://www.mcorpcx.com/20180930/role/statement-note-7-concentrations-percentage-of-sales-and-the-concentrations-details Note 7 - Concentrations - Percentage of Sales and the Concentrations (Details) Details 30 false false R31.htm 030 - Disclosure - Note 8 - Debt (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-8-debt-details-textual Note 8 - Debt (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-8-debt 31 false false R32.htm 031 - Disclosure - Note 9 - Going Concern (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-9-going-concern-details-textual Note 9 - Going Concern (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-9-going-concern 32 false false R33.htm 032 - Disclosure - Note 10 - Basic and Diluted Net Income / (Loss) Per Share (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-10-basic-and-diluted-net-income-loss-per-share-details-textual Note 10 - Basic and Diluted Net Income / (Loss) Per Share (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-10-basic-and-diluted-net-income-loss-per-share-tables 33 false false R34.htm 033 - Disclosure - Note 10 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) Sheet http://www.mcorpcx.com/20180930/role/statement-note-10-basic-and-diluted-net-income-loss-per-share-computations-for-basic-and-diluted-net-income-loss-per-share-details Note 10 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) Details http://www.mcorpcx.com/20180930/role/statement-note-10-basic-and-diluted-net-income-loss-per-share-tables 34 false false R35.htm 034 - Disclosure - Note 11 - Related-party Transactions (Details Textual) Sheet http://www.mcorpcx.com/20180930/role/statement-note-11-relatedparty-transactions-details-textual Note 11 - Related-party Transactions (Details Textual) Details http://www.mcorpcx.com/20180930/role/statement-note-11-relatedparty-transactions 35 false false All Reports Book All Reports mccx-20180930.xml mccx-20180930.xsd mccx-20180930_cal.xml mccx-20180930_def.xml mccx-20180930_lab.xml mccx-20180930_pre.xml http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 52 0001437749-18-020775-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-18-020775-xbrl.zip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�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�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